Dow (DOW) 10-Q 26 Apr 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	Dow Inc.
Entity Tax Identification Number	30-1128146
Entity File Number	001-38646
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Central Index Key	0001751788
Current Fiscal Year End Date	--12-31
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	DOW
Security Exchange Name	NYSE
Entity Listing, Par Value Per Share | $ / shares	$ 0.01
Entity Common Stock, Shares Outstanding | shares	703,205,830
The Dow Chemical Company
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Information [Line Items]
Entity Registrant Name	The Dow Chemical Company
Entity Tax Identification Number	38-1285128
Entity File Number	001-03433
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Central Index Key	0000029915
Current Fiscal Year End Date	--12-31
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
Entity Listings [Line Items]
Entity Listing, Par Value Per Share | $ / shares	$ 0.01
Entity Common Stock, Shares Outstanding | shares	100
The Dow Chemical Company | 0.500% Notes due March 15, 2027
Entity Listings [Line Items]
Title of 12(b) Security	0.500% Notes due March 15, 2027
Trading Symbol	DOW/27
Security Exchange Name	NYSE
The Dow Chemical Company | 1.125% Notes due March 15, 2032
Entity Listings [Line Items]
Title of 12(b) Security	1.125% Notes due March 15, 2032
Trading Symbol	DOW/32
Security Exchange Name	NYSE
The Dow Chemical Company | 1.875% Notes due March 15, 2040
Entity Listings [Line Items]
Title of 12(b) Security	1.875% Notes due March 15, 2040
Trading Symbol	DOW/40
Security Exchange Name	NYSE
The Dow Chemical Company | 4.625% Notes due October 1, 2044
Entity Listings [Line Items]
Title of 12(b) Security	4.625% Notes due October 1, 2044
Trading Symbol	DOW/44
Security Exchange Name	NYSE

Dow Consolidated Statements of

Dow Consolidated Statements of Income Statement - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 10,765	$ 11,851
Cost of sales	9,488	10,629
Research and development expenses	204	214
Selling, general and administrative expenses	442	428
Amortization of intangibles	81	81
Restructuring and asset related charges - net	45	541
Equity in earnings (losses) of nonconsolidated affiliates	17	(48)
Sundry income (expense) - net	61	79
Interest income	65	76
Interest expense and amortization of debt discount	199	185
Income (loss) before income taxes	449	(120)
Credit for income taxes	(89)	(47)
Net income (loss)	538	(73)
Net income attributable to noncontrolling interests	22	20
Net income (loss) available for The Dow Chemical Company common stockholder	$ 516	$ (93)
Earnings (loss) per common share - basic	$ 0.73	$ (0.13)
Earnings (loss) per common share - diluted	$ 0.73	$ (0.13)
Weighted-average common shares outstanding - basic	704.5	708.2
Weighted-average common shares outstanding - diluted	705.5	708.2

Dow Consolidated Statements o_2

Dow Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 538	$ (73)
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(6)	31
Cumulative translation adjustments	(122)	101
Pension and other postretirement benefit plans	17	6
Derivative instruments	(22)	(64)
Total other comprehensive income (loss)	(133)	74
Comprehensive income (loss)	405	1
Comprehensive income attributable to noncontrolling interests, net of tax	22	20
Comprehensive income (loss) attributable to Dow Inc.	$ 383	$ (19)

Dow Consolidated Balance Sheets

Dow Consolidated Balance Sheets Statement - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Cash and Cash Equivalents	$ 3,723	$ 2,987
Trade (net of allowance for doubtful receivables - 2024: $71; 2023: $81)	5,212	4,718
Other	1,857	1,896
Inventories	6,373	6,076
Other current assets	1,283	1,937
Total current assets	18,448	17,614
Investment in nonconsolidated affiliates	1,240	1,267
Other investments (investments carried at fair value - 2024: $2,030; 2023: $1,877)	2,831	2,740
Noncurrent receivables	382	438
Total investments	4,453	4,445
Property	60,662	60,203
Less: Accumulated depreciation	39,401	39,137
Net property	21,261	21,066
Goodwill	8,590	8,641
Other intangible assets (net of accumulated amortization - 2024: $5,445; 2023: $5,374)	1,967	2,072
Operating lease right-of-use assets	1,364	1,320
Deferred income tax assets	1,402	1,486
Deferred charges and other assets	1,332	1,323
Total other assets	14,655	14,842
Total Assets	58,817	57,967
Notes payable	55	62
Long-term debt due within one year	118	117
Accounts payable - Trade	4,940	4,529
Accounts payable - Other	1,847	1,797
Operating lease liabilities - current	324	329
Income taxes payable	448	419
Accrued Liabilities, Current	2,517	2,704
Total current liabilities	10,249	9,957
Long-Term Debt	16,170	14,907
Deferred income tax liabilities	383	399
Pension and other postretirement benefits - noncurrent	4,800	4,932
Asbestos-related liabilities - noncurrent	761	788
Operating lease liabilities - noncurrent	1,071	1,032
Other noncurrent obligations	6,466	6,844
Total other noncurrent liabilities	13,481	13,995
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2024: 781,810,357 shares; 2023: 778,595,514 shares)	8	8
Additional Paid in Capital, Common Stock	8,942	8,880
Retained earnings	21,796	21,774
Accumulated other comprehensive loss	(7,814)	(7,681)
Treasury stock at cost (2024: 78,604,527 shares; 2023: 76,302,081 shares)	(4,507)	(4,374)
Dow Inc.’s stockholders’ equity	18,425	18,607
Noncontrolling interests	492	501
Total equity	18,917	19,108
Total Liabilities and Equity	$ 58,817	$ 57,967

Dow Consolidated Balance Shee_2

Dow Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss, Current	$ 71	$ 81
Investments, Fair Value Disclosure	2,030	1,877
Finite-Lived Intangible Assets, Accumulated Amortization	$ 5,445	$ 5,374
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares, Issued	781,810,357	778,595,514
Treasury Stock, Common, Shares	78,604,527	76,302,081

Dow Consolidated Statements o_3

Dow Consolidated Statements of Cash Flows Statement - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Cash Flows [Abstract]
Net income (loss)	$ 538	$ (73)
Depreciation and amortization	720	648
Provision (credit) for deferred income tax	7	(418)
Earnings of nonconsolidated affiliates less than dividends received	75	102
Net periodic pension benefit credit	(48)	(23)
Pension contributions	(34)	(41)
Net gain on sales of assets, businesses and investments	(11)	(49)
Restructuring and asset related charges - net	45	541
Other net loss	92	347
Accounts and notes receivable	(600)	(68)
Inventories	(297)	163
Accounts payable	398	(631)
Other assets and liabilities, net	(425)	33
Cash provided by operating activities - continuing operations	460	531
Cash provided by operating activities - discontinued operations	4	4
Cash provided by operating activities	464	535
Capital expenditures	(714)	(440)
Investment in gas field developments	(52)	(55)
Purchases of previously leased assets	0	(2)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested	2	57
Acquisitions of property and businesses, net of cash acquired	0	(23)
Investments in and loans to nonconsolidated affiliates	(2)	0
Distributions and loan repayments from nonconsolidated affiliates	0	1
Purchases of investments	(679)	(165)
Proceeds from sales and maturities of investments	1,173	512
Other investing activities, net	1	(35)
Cash used for investing activities	(271)	(150)
Changes in short-term notes payable	(20)	(91)
Proceeds from issuance of short-term debt greater than three months	7	0
Proceeds from issuance of long-term debt	1,381	13
Payments on long-term debt	(93)	(156)
Collections on securitization programs	4	0
Purchases of treasury stock	(200)	(125)
Proceeds from issuance of stock	42	55
Transaction financing, debt issuance and other costs	(11)	0
Employee taxes paid for share-based payment arrangements	(37)	(41)
Distributions to noncontrolling interests	(14)	(13)
Dividends paid to stockholders	(493)	(496)
Cash provided by (used for) financing activities	566	(854)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(54)	(41)
Increase (decrease) in cash, cash equivalents and restricted cash	705	(510)
Cash, cash equivalents and restricted cash at beginning of period	3,048	3,940
Cash, cash equivalents and restricted cash at end of period	3,753	3,430
Less: Restricted cash and cash equivalents, included in "Other current assets"	30	111
Cash and cash equivalents and end of period	$ 3,723	$ 3,319

Dow Consolidated Statements o_4

Dow Consolidated Statements of Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock, Common
Total equity		$ 8	$ 8,540	$ 23,180	$ (7,139)	$ (3,871)
Stock Issued During Period, Value, Common Stock			55
APIC, Share-based Payment Arrangement, Increase for Cost Recognition			56
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans			(44)
Net Income (Loss) Available to Common Stockholders, Basic	$ (96)			(93)
Dividends, Common Stock				(496)
Stockholders' Equity, Other				(7)
Other Comprehensive Income (Loss), Net of Tax	$ 74				74
Treasury Stock, Value, Acquired, Cost Method						(126)
Stock Issued During Period, Value Treasury Stock Reissued - compensation and benefit plans						44
Common Stock, Dividends, Per Share, Declared	$ 0.70
Transfer of Business Under Common Control				0
Dow Inc.’s stockholders’ equity	$ 20,181
Noncontrolling interests	534
Total equity	20,715	8	8,607	22,584	(7,065)	(3,953)
Dow Inc.’s stockholders’ equity	18,607
Noncontrolling interests	501
Total equity	19,108	8	8,880	21,774	(7,681)	(4,374)
Stock Issued During Period, Value, Common Stock			42
APIC, Share-based Payment Arrangement, Increase for Cost Recognition			87
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans			(67)
Net Income (Loss) Available to Common Stockholders, Basic	513			516
Dividends, Common Stock				(493)
Stockholders' Equity, Other				(11)
Other Comprehensive Income (Loss), Net of Tax	$ (133)				(133)
Treasury Stock, Value, Acquired, Cost Method						(200)
Stock Issued During Period, Value Treasury Stock Reissued - compensation and benefit plans						67
Common Stock, Dividends, Per Share, Declared	$ 0.70
Transfer of Business Under Common Control				10
Dow Inc.’s stockholders’ equity	$ 18,425
Noncontrolling interests	492
Total equity	$ 18,917	$ 8	$ 8,942	$ 21,796	$ (7,814)	$ (4,507)

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net sales	$ 10,765	$ 11,851
Cost of sales	9,488	10,629
Research and development expenses	204	214
Selling, general and administrative expenses	442	428
Amortization of intangibles	81	81
Restructuring and asset related charges - net	45	541
Equity in earnings (losses) of nonconsolidated affiliates	17	(48)
Sundry income (expense) - net	61	79
Interest income	65	76
Interest expense and amortization of debt discount	199	185
Income (loss) before income taxes	449	(120)
Credit for income taxes	(89)	(47)
Net income (loss)	538	(73)
Net income attributable to noncontrolling interests	22	20
Net income (loss) available for The Dow Chemical Company common stockholder	516	(93)
The Dow Chemical Company
Net sales	10,765	11,851
Cost of sales	9,487	10,628
Research and development expenses	204	214
Selling, general and administrative expenses	442	428
Amortization of intangibles	81	81
Restructuring and asset related charges - net	45	541
Equity in earnings (losses) of nonconsolidated affiliates	17	(48)
Sundry income (expense) - net	61	69
Interest income	69	78
Interest expense and amortization of debt discount	199	185
Income (loss) before income taxes	454	(127)
Credit for income taxes	(89)	(47)
Net income (loss)	543	(80)
Net income attributable to noncontrolling interests	22	20
Net income (loss) available for The Dow Chemical Company common stockholder	$ 521	$ (100)

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net income (loss)	$ 538	$ (73)
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(6)	31
Cumulative translation adjustments	(122)	101
Pension and other postretirement benefit plans	17	6
Derivative instruments	(22)	(64)
Other Comprehensive Income (Loss), Net of Tax	(133)	74
Comprehensive Income	405	1
Comprehensive income attributable to noncontrolling interests, net of tax	22	20
Comprehensive income (loss) attributable to The Dow Chemical Company	383	(19)
The Dow Chemical Company
Net income (loss)	543	(80)
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(6)	31
Cumulative translation adjustments	(122)	101
Pension and other postretirement benefit plans	17	6
Derivative instruments	(22)	(64)
Other Comprehensive Income (Loss), Net of Tax	(133)	74
Comprehensive Income	410	(6)
Comprehensive income attributable to noncontrolling interests, net of tax	22	20
Comprehensive income (loss) attributable to The Dow Chemical Company	$ 388	$ (26)

TDCC Consolidated Balance Sheet

TDCC Consolidated Balance Sheets (Statement) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Cash and Cash Equivalents	$ 3,723	$ 2,987
Trade (net of allowance for doubtful receivables - 2024: $71; 2023: $81)	5,212	4,718
Other	1,857	1,896
Inventories	6,373	6,076
Other current assets	1,283	1,937
Total current assets	18,448	17,614
Investment in nonconsolidated affiliates	1,240	1,267
Other investments (investments carried at fair value - 2024: $2,030; 2023: $1,877)	2,831	2,740
Noncurrent receivables	382	438
Total investments	4,453	4,445
Property	60,662	60,203
Less: Accumulated depreciation	39,401	39,137
Net property	21,261	21,066
Goodwill	8,590	8,641
Other intangible assets (net of accumulated amortization - 2024: $5,445; 2023: $5,374)	1,967	2,072
Operating lease right-of-use assets	1,364	1,320
Deferred income tax assets	1,402	1,486
Deferred charges and other assets	1,332	1,323
Total other assets	14,655	14,842
Total Assets	58,817	57,967
Notes payable	55	62
Long-term debt due within one year	118	117
Accounts payable - Trade	4,940	4,529
Accounts payable - Other	1,847	1,797
Operating lease liabilities - current	324	329
Income taxes payable	448	419
Accrued Liabilities, Current	2,517	2,704
Total current liabilities	10,249	9,957
Long-Term Debt	16,170	14,907
Deferred income tax liabilities	383	399
Pension and other postretirement benefits - noncurrent	4,800	4,932
Asbestos-related liabilities - noncurrent	761	788
Operating lease liabilities - noncurrent	1,071	1,032
Other noncurrent obligations	6,466	6,844
Total other noncurrent liabilities	13,481	13,995
Common stock (authorized and issued 100 shares of $0.01 par value each)	8	8
Additional Paid in Capital, Common Stock	8,942	8,880
Retained earnings	21,796	21,774
Accumulated other comprehensive loss	(7,814)	(7,681)
Dow Inc.’s stockholders’ equity	18,425	18,607
Noncontrolling interests	492	501
Total equity	18,917	19,108
Total Liabilities and Equity	58,817	57,967
The Dow Chemical Company
Cash and Cash Equivalents	3,723	2,987
Trade (net of allowance for doubtful receivables - 2024: $71; 2023: $81)	5,212	4,718
Other	1,868	1,997
Inventories	6,373	6,076
Other current assets	1,249	1,898
Total current assets	18,425	17,676
Investment in nonconsolidated affiliates	1,240	1,267
Other investments (investments carried at fair value - 2024: $2,030; 2023: $1,877)	2,831	2,740
Noncurrent receivables	371	424
Total investments	4,442	4,431
Property	60,662	60,203
Less: Accumulated depreciation	39,401	39,137
Net property	21,261	21,066
Goodwill	8,590	8,641
Other intangible assets (net of accumulated amortization - 2024: $5,445; 2023: $5,374)	1,967	2,072
Operating lease right-of-use assets	1,364	1,320
Deferred income tax assets	1,402	1,486
Deferred charges and other assets	1,332	1,323
Total other assets	14,655	14,842
Total Assets	58,783	58,015
Notes payable	59	62
Long-term debt due within one year	118	117
Accounts payable - Trade	4,940	4,529
Accounts payable - Other	1,877	1,818
Operating lease liabilities - current	324	329
Income taxes payable	448	419
Accrued Liabilities, Current	2,394	2,575
Total current liabilities	10,160	9,849
Long-Term Debt	16,170	14,907
Deferred income tax liabilities	383	399
Pension and other postretirement benefits - noncurrent	4,800	4,932
Asbestos-related liabilities - noncurrent	761	788
Operating lease liabilities - noncurrent	1,071	1,032
Other noncurrent obligations	6,326	6,702
Total other noncurrent liabilities	13,341	13,853
Common stock (authorized and issued 100 shares of $0.01 par value each)	0	0
Additional Paid in Capital, Common Stock	9,220	9,091
Retained earnings	17,214	17,495
Accumulated other comprehensive loss	(7,814)	(7,681)
Dow Inc.’s stockholders’ equity	18,620	18,905
Noncontrolling interests	492	501
Total equity	19,112	19,406
Total Liabilities and Equity	$ 58,783	$ 58,015

TDCC Consolidated Statements of

TDCC Consolidated Statements of Cash Flows Statement - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net income (loss)	$ 538	$ (73)
Depreciation and amortization	720	648
Provision (credit) for deferred income tax	7	(418)
Earnings of nonconsolidated affiliates less than dividends received	75	102
Net periodic pension benefit credit	(48)	(23)
Pension contributions	(34)	(41)
Net gain on sales of assets, businesses and investments	(11)	(49)
Restructuring and asset related charges - net	45	541
Other net loss	92	347
Accounts and notes receivable	(600)	(68)
Inventories	(297)	163
Accounts payable	398	(631)
Other assets and liabilities, net	(425)	33
Cash provided by operating activities	464	535
Capital expenditures	(714)	(440)
Investment in gas field developments	(52)	(55)
Purchases of previously leased assets	0	(2)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested	2	57
Acquisitions of property and businesses, net of cash acquired	0	(23)
Investments in and loans to nonconsolidated affiliates	(2)	0
Distributions and loan repayments from nonconsolidated affiliates	0	1
Purchases of investments	(679)	(165)
Proceeds from sales and maturities of investments	1,173	512
Other investing activities, net	1	(35)
Cash used for investing activities	(271)	(150)
Changes in short-term notes payable	(20)	(91)
Proceeds from issuance of short-term debt greater than three months	7	0
Proceeds from issuance of long-term debt	1,381	13
Payments on long-term debt	(93)	(156)
Collections on securitization programs	4	0
Proceeds from issuance of stock	42	55
Transaction financing, debt issuance and other costs	(11)	0
Employee taxes paid for share-based payment arrangements	(37)	(41)
Distributions to noncontrolling interests	(14)	(13)
Dividends paid to stockholders	(493)	(496)
Cash provided by (used for) financing activities	566	(854)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(54)	(41)
Increase (decrease) in cash, cash equivalents and restricted cash	705	(510)
Cash, cash equivalents and restricted cash at beginning of period	3,048	3,940
Cash, cash equivalents and restricted cash at end of period	3,753	3,430
Less: Restricted cash and cash equivalents, included in "Other current assets"	30	111
Cash and cash equivalents and end of period	3,723	3,319
The Dow Chemical Company
Net income (loss)	543	(80)
Depreciation and amortization	720	648
Provision (credit) for deferred income tax	7	(418)
Earnings of nonconsolidated affiliates less than dividends received	75	102
Net periodic pension benefit credit	(48)	(23)
Pension contributions	(34)	(41)
Net gain on sales of assets, businesses and investments	(11)	(49)
Restructuring and asset related charges - net	45	541
Other net loss	92	348
Accounts and notes receivable	(600)	(68)
Inventories	(297)	163
Accounts payable	398	(631)
Other assets and liabilities, net	(421)	42
Cash provided by operating activities	469	534
Capital expenditures	(714)	(440)
Investment in gas field developments	(52)	(55)
Purchases of previously leased assets	0	(2)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested	2	57
Acquisitions of property and businesses, net of cash acquired	0	(23)
Investments in and loans to nonconsolidated affiliates	(2)	0
Distributions and loan repayments from nonconsolidated affiliates	0	1
Purchases of investments	(679)	(165)
Proceeds from sales and maturities of investments	1,173	512
Other investing activities, net	1	(35)
Cash used for investing activities	(271)	(150)
Changes in short-term notes payable	(20)	(91)
Proceeds from issuance of short-term debt greater than three months	7	0
Proceeds from issuance of long-term debt	1,381	13
Payments on long-term debt	(93)	(156)
Collections on securitization programs	4	0
Proceeds from issuance of stock	42	55
Transaction financing, debt issuance and other costs	(11)	0
Employee taxes paid for share-based payment arrangements	(37)	(41)
Distributions to noncontrolling interests	(14)	(13)
Dividends paid to stockholders	(698)	(620)
Cash provided by (used for) financing activities	561	(853)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(54)	(41)
Increase (decrease) in cash, cash equivalents and restricted cash	705	(510)
Cash, cash equivalents and restricted cash at beginning of period	3,048	3,940
Cash, cash equivalents and restricted cash at end of period	3,753	3,430
Less: Restricted cash and cash equivalents, included in "Other current assets"	30	111
Cash and cash equivalents and end of period	$ 3,723	$ 3,319

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss	Dow Inc. [Member] Retained Earnings [Member]	The Dow Chemical Company	The Dow Chemical Company Common Stock [Member]	The Dow Chemical Company Additional Paid-in Capital [Member]	The Dow Chemical Company Retained Earnings [Member]	The Dow Chemical Company Accumulated Other Comprehensive Loss	The Dow Chemical Company Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2022		$ 8	$ 8,540	$ 23,180	$ (7,139)			$ 0	$ 8,627	$ 19,472	$ (7,139)
Stock Issued									55
Stock-based compensation and allocation of ESOP shares			56						56
Net income available for The Dow Chemical Company common stockholder	$ (96)			(93)						(100)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees						$ (620)
Other				7						(6)
Other comprehensive income	74				74		$ 74				74
Total Equity, Ending at Mar. 31, 2023	20,715	8	8,607	22,584	(7,065)		20,953	0	8,738	18,746	(7,065)	$ 534
The Dow Chemical Company’s stockholders’ equity	20,181						20,419
The Dow Chemical Company’s stockholders’ equity	18,607						18,905
Total Equity, Beginning at Dec. 31, 2023	19,108	8	8,880	21,774	(7,681)		19,406	0	9,091	17,495	(7,681)
Stock Issued									42
Stock-based compensation and allocation of ESOP shares			87						87
Net income available for The Dow Chemical Company common stockholder	513			516						521
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees						$ (791)
Other				11						(11)
Other comprehensive income	(133)				(133)		(133)				(133)
Total Equity, Ending at Mar. 31, 2024	18,917	$ 8	$ 8,942	$ 21,796	$ (7,814)		19,112	$ 0	$ 9,220	$ 17,214	$ (7,814)	$ 492
The Dow Chemical Company’s stockholders’ equity	$ 18,425						$ 18,620

Dow Consolidated Statements o_5

Dow Consolidated Statements of Income - Supplemental Info - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental Income Statement Elements [Abstract]
Depreciation	$ 481	$ 475
Capital expenditures	$ 714	$ 440

TDCC Consolidated Statements _2

TDCC Consolidated Statements of Income - Supplemental Info - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Depreciation	$ 481	$ 475
Capital expenditures	714	440
The Dow Chemical Company
Depreciation	481	475
Capital expenditures	$ 714	$ 440

TDCC Consolidated Balance She_2

TDCC Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss, Current	$ 71	$ 81
Investments, Fair Value Disclosure	2,030	1,877
Finite-Lived Intangible Assets, Accumulated Amortization	$ 5,445	$ 5,374
Common Stock, Shares, Issued	781,810,357	778,595,514
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
The Dow Chemical Company
Accounts Receivable, Allowance for Credit Loss, Current	$ 71	$ 81
Finite-Lived Intangible Assets, Accumulated Amortization	$ 5,445	$ 5,374
Common Stock, Shares, Issued	100	100
Common Stock, Shares Authorized	100	100
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01

CONSOLIDATED FINANCIAL STATEMEN

CONSOLIDATED FINANCIAL STATEMENTS (Notes)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
CONSOLIDATED FINANCIAL STATEMENTS	CONSOLIDATED FINANCIAL STATEMENTS Basis of Presentation Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 10-K"). As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC. Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.

RECENT ACCOUNTING GUIDANCE (Not

RECENT ACCOUNTING GUIDANCE (Notes)	3 Months Ended
	Mar. 31, 2024
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING GUIDANCE	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance On January 1, 2024, the Company adopted the amendments in Accounting Standards Update ("ASU") 2023-02, "Investments — Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method" and elected to account for certain tax equity investments using the proportional amortization method, as provided by the ASU. Under the proportional amortization method, an entity amortizes the initial cost of tax equity investments in proportion to the income tax credits and other income tax benefits received and recognizes the net amortization and income tax credits and other income tax benefits in the income statement as a component of income tax expense (benefit). The adoption of the ASU did not have a material impact on the Company's consolidated financial statements. Accounting Guidance Issued But Not Adopted at March 31, 2024 In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, allowing financial statement users to better understand the components of a segment's profit or loss to assess potential future cash flows for each reportable segment and the entity as a whole. The amendments expand a public entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements. SEC Final Rules Not Adopted at March 31, 2024 In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. The final rules include requirements to disclose material climate-related risks; activities to mitigate or adapt to such risks; information about the board of directors' oversight of climate-related risks and management’s role in managing material climate-related risks; and information on any climate-related targets or goals that are material to the registrant's business, results of operations, or financial condition. Registrants are also required to disclose the financial statement effects of severe weather events and other natural conditions in the notes to the financial statements. Certain large registrants are also required to disclose Scope 1 and Scope 2 greenhouse gas ("GHG") emissions, when material. The final rules include a phased-in compliance period for all registrants. As a large accelerated filer, most disclosure requirements are effective for the Company beginning with the year ending December 31, 2025. GHG emissions disclosures are required for the year ending December 31, 2026. The Company will also be required to obtain limited assurance on its Scope 1 and Scope 2 GHG emissions disclosures beginning with the year ending December 31, 2029, with reasonable assurance required beginning with the year ending December 31, 2033. In April 2024, the SEC informed the U.S. Court of Appeals for the Eighth Circuit ("Court") that it would voluntarily stay the final rules until various legal challenges are resolved by the Court. The Company is currently evaluating the impact of the final rules on its consolidated financial statements and annual disclosures.

REVENUE (Notes)

REVENUE (Notes)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	REVENUE Revenue Recognition The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 98 percent for the three months ended March 31, 2024 (99 percent for the three months ended March 31, 2023). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract. Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2024, the Company had unfulfilled performance obligations of $743 million ($744 million at December 31, 2023) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next six years. The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 20 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. Disaggregation of Revenue The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below: Net Trade Sales by Segment and Business Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Hydrocarbons & Energy $ 1,467 $ 1,874 Packaging and Specialty Plastics 3,963 4,240 Packaging & Specialty Plastics $ 5,430 $ 6,114 Industrial Solutions $ 1,028 $ 1,139 Polyurethanes & Construction Chemicals 1,977 2,234 Other 3 5 Industrial Intermediates & Infrastructure $ 3,008 $ 3,378 Coatings & Performance Monomers $ 885 $ 858 Consumer Solutions 1,267 1,418 Performance Materials & Coatings $ 2,152 $ 2,276 Corporate $ 175 $ 83 Total $ 10,765 $ 11,851 Net Trade Sales by Geographic Region Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 U.S. & Canada $ 4,130 $ 4,450 EMEAI 1 3,484 4,053 Asia Pacific 1,921 2,047 Latin America 1,230 1,301 Total $ 10,765 $ 11,851 1. Europe, Middle East, Africa and India. Contract Assets and Liabilities The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract. Revenue recognized in the first three months of 2024 from amounts included in contract liabilities at the beginning of the period was approximately $40 million (approximately $40 million in the first three months of 2023). In the first three months of 2024, no contract assets were reclassified to receivables as a result of the right to the transaction consideration becoming unconditional (approximately $30 million in the first three months of 2023). The following table summarizes contract assets and liabilities at March 31, 2024 and December 31, 2023: Contract Assets and Liabilities Balance Sheet Classification Mar 31, 2024 Dec 31, 2023 In millions Accounts and notes receivable - trade Accounts and notes receivable - trade $ 5,212 $ 4,718 Contract assets - current Other current assets $ 13 $ 13 Contract assets - noncurrent Deferred charges and other assets $ 4 $ 4 Contract liabilities - current Accrued and other current liabilities $ 210 $ 195 Contract liabilities - noncurrent Other noncurrent obligations $ 1,600 $ 1,642

RESTRUCTURING AND ASSET RELATED

RESTRUCTURING AND ASSET RELATED CHARGES - NET (Notes)	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING AND ASSET RELATED CHARGES - NET Charges for restructuring programs and other asset related charges, which includes asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs, see Note 4 to the Consolidated Financial Statements included in the 2023 10-K. 2023 Restructuring Program On January 25, 2023, the Dow Inc. Board of Directors ("Board") approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the global recessionary environment and to enhance its agility and long-term competitiveness across the economic cycle. These actions are expected to be substantially complete by the end of 2024. In the first quarter of 2024, the Company recorded additional pretax restructuring charges of $8 million for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets within the Industrial Intermediates & Infrastructure segment. The impacted facilities are expected to be shutdown by the end of 2025. The following table summarizes the activities related to the 2023 Restructuring Program, including segment information: 2023 Restructuring Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Total In millions Packaging & Specialty Plastics $ — $ 1 $ 1 Industrial Intermediates & Infrastructure — 40 40 Performance Materials & Coatings — 49 49 Corporate 344 107 451 Total restructuring charges $ 344 $ 197 $ 541 Charges against the reserve — (197) (197) Cash payments (11) — (11) Reserve balance at Mar 31, 2023 $ 333 $ — $ 333 Industrial Intermediates & Infrastructure $ — $ 8 $ 8 Total restructuring charges $ — $ 8 $ 8 Charges against the reserve — (8) (8) Cash payments (60) — (60) Reserve balance at Jun 30, 2023 $ 273 $ — $ 273 Cash payments (110) — (110) Reserve balance at Sep 30, 2023 $ 163 $ — $ 163 Industrial Intermediates & Infrastructure $ — $ 2 $ 2 Corporate — (16) (16) Total restructuring charges $ — $ (14) $ (14) Charges against the reserve — 14 14 Cash payments (41) — (41) Reserve balance at Dec 31, 2023 $ 122 $ — $ 122 Industrial Intermediates & Infrastructure $ — $ 8 $ 8 Total restructuring charges $ — $ 8 $ 8 Charges against the reserve — (8) (8) Cash payments (48) — (48) Reserve balance at Mar 31, 2024 $ 74 $ — $ 74 At March 31, 2024, $70 million of the reserve balance was included in "Accrued and other current liabilities" ($101 million at December 31, 2023) and $4 million was included in "Other noncurrent obligations" ($21 million at December 31, 2023) in the consolidated balance sheets. The Company recorded pretax restructuring charges of $543 million inception-to-date under the 2023 Restructuring Program, consisting of severance and related benefit costs of $344 million and asset write-downs and write-offs of $199 million. Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, and costs associated with the Company's productivity and efficiency actions, are expected to result in additional cash expenditures of approximately $255 million, primarily through the end of 2024. Restructuring implementation and efficiency costs totaled $46 million in the first quarter of 2024. Asset Related Charges In the first quarter of 2024, the Company recognized pretax impairment charges of $37 million related primarily to write-downs of certain manufacturing assets in the U.S. & Canada and EMEAI. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. See Note 18 for additional information.

SUPPLEMENTARY INFORMATION (Note

SUPPLEMENTARY INFORMATION (Notes)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplementary Information Disclosure [Text Block]	SUPPLEMENTARY INFORMATION Dow Inc. Sundry Income (Expense) – Net Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Non-operating pension and other postretirement benefit plan net credits 1 $ 61 $ 96 Foreign exchange losses 2 (23) (102) Gain on sales of other assets and investments 3 9 65 Asset impairments and related costs 4 — (18) Indemnification and other transaction related costs 5 — 9 Other - net 14 29 Total sundry income (expense) – net $ 61 $ 79 1. See Note 15 for additional information. 2. Foreign exchange losses for the three months ended March 31, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso. Foreign exchange losses for the three months ended March 31, 2023 relate primarily to exposures in the Argentine peso. 3. The three months ended March 31, 2023 includes gains associated with the sale of shares of a previously impaired equity method investment. 4. Certain obligations associated with a previously impaired equity method investment. 5. Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva") as part of the separation and distribution. Sundry income (expense) - net for TDCC for the three months ended March 31, 2024 and 2023 is substantially the same as that of Dow Inc., with the primary difference related to indemnification and other transaction related costs recorded on Dow Inc. Therefore, TDCC sundry income (expense) - net is not disclosed separately. Other Investments The Company has investments in company-owned life insurance policies ("COLI"), which are recorded at their cash surrender value as of each balance sheet date, as provided below: Investments in Company-Owned Life Insurance Mar 31, 2024 Dec 31, 2023 In millions Gross cash value $ 638 $ 623 Less: Existing drawdowns 1 198 97 Less: Accrued interest on drawdowns 2 2 — Investments in company-owned life insurance 3 $ 438 $ 526 1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows. 2. Included in "Sundry income (expense) - net" in the consolidated statements of income. 3. Classified as "Other investments" in the consolidated balance sheets. Supplier Finance Program The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At March 31, 2024, outstanding obligations confirmed as valid under the SCF program were $291 million ($285 million at December 31, 2023), included in “Accounts payable – Trade” in the consolidated balance sheets.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Tax Disclosure	INCOME TAXES As the financial statements for Dow Inc. and TDCC are substantially similar, including the credit for income taxes, the following income tax discussion does not include reference to TDCC's credit for income taxes or its effective tax rate. The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. In the first quarter of 2024, the Company reported a credit for income taxes of $89 million, resulting in an effective tax rate of negative 19.8 percent. In the first quarter of 2023, the Company reported a credit for income taxes of $47 million, resulting in an effective tax rate of 39.2 percent. The credit for income taxes for the first quarter of 2024 was primarily due to a reassessment of interest and penalties related to a tax matter in a foreign jurisdiction, for which the Company recorded a tax credit of $194 million. The credit for income taxes in 2023 was primarily due to a pretax loss in 2023 and benefits related to deferred tax assets in a foreign jurisdiction, partially offset by a remeasurement of uncertain tax positions.

EARNINGS PER SHARE (Notes)

EARNINGS PER SHARE (Notes)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE CALCULATIONS The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2024 and 2023. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income (Loss) for Earnings Per Share Calculations Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Net income (loss) $ 538 $ (73) Net income attributable to noncontrolling interests 22 20 Net income attributable to participating securities 1 3 3 Net income (loss) attributable to common stockholders $ 513 $ (96) Earnings (Loss) Per Share - Basic and Diluted Three Months Ended Dollars per share Mar 31, 2024 Mar 31, 2023 Earnings (loss) per common share - basic $ 0.73 $ (0.13) Earnings (loss) per common share - diluted $ 0.73 $ (0.13) Share Count Information Three Months Ended Shares in millions Mar 31, 2024 Mar 31, 2023 Weighted-average common shares outstanding - basic 704.5 708.2 Plus dilutive effect of equity compensation plans 2 1.0 — Weighted-average common shares outstanding - diluted 705.5 708.2 Stock units excluded from EPS calculations 3 8.8 22.1 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. 2. The three months ended March 31, 2023 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis. 3. These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

INVENTORIES (Notes)

INVENTORIES (Notes)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The following table provides a breakdown of inventories: Inventories Mar 31, 2024 Dec 31, 2023 In millions Finished goods $ 3,741 $ 3,413 Work in process 1,318 1,234 Raw materials 767 746 Supplies 983 992 Total $ 6,809 $ 6,385 Adjustment of inventories to the LIFO basis (436) (309) Total inventories $ 6,373 $ 6,076

TRANSFERS OF FINANCIAL ASSETS

TRANSFERS OF FINANCIAL ASSETS	3 Months Ended
	Mar. 31, 2024
Transfers and Servicing [Abstract]
TRANSFERS OF FINANCIAL ASSETS	TRANSFERS OF FINANCIAL ASSETS Accounts Receivable Programs The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. In the first quarter of 2024, the Company sold $279 million of receivables under the Programs (no sales of receivables in the first three months of 2023). Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. At March 31, 2024, the Company had $273 million outstanding ($79 million outstanding at December 31, 2023). Losses on transfers of receivables were insignificant in the first quarter of 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 11 for additional information related to guarantees. Beginning in the fourth quarter of 2023, the Company has access to an accounts receivable discounting facility that covers receivables generated from sales in EMEAI. Beginning in the first quarter of 2024, the Company has access to a similar accounts receivable discounting facility that covers receivables generated from sales in Asia Pacific. Under the terms of these discounting facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. In the first quarter of 2024, the Company sold $148 million of receivables under these facilities (no sales of receivables in the first three months of 2023). Under the terms of the discounting facilities, the Company continues to service the receivables from the customer and had $148 million outstanding at March 31, 2024 ($91 million outstanding at December 31, 2023). Losses on transfers of receivables were insignificant in the first quarter of 2024.

NOTES PAYABLE, LONG-TERM DEBT A

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Notes)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt Disclosure	NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable Mar 31, 2024 Dec 31, 2023 In millions Notes payable to banks and other lenders $ 55 $ 62 Period-end average interest rates 34.55 % 33.84 % Long-Term Debt 2024 Average Rate Mar 31, 2024 2023 Average Rate Dec 31, 2023 In millions Promissory notes and debentures: Final maturity 2025 5.63 % $ 333 5.63 % $ 333 Final maturity 2028 4.80 % 600 4.80 % 600 Final maturity 2029 7.58 % 1,367 7.58 % 1,367 Final maturity 2030 and thereafter 1 5.10 % 10,103 5.07 % 8,861 Other facilities: Foreign currency notes and loans, various rates and maturities 3.89 % 2,645 1.18 % 2,653 InterNotes®, varying maturities through 2054 4.14 % 595 4.12 % 595 Finance lease obligations 2 908 873 Unamortized debt discount and issuance costs (263) (258) Long-term debt due within one year 3 (118) (117) Long-term debt $ 16,170 $ 14,907 1. Cost includes net fair value hedge adjustment gains o f $42 million at March 31, 2024 ($49 million at December 31, 2023). See Note 17 for additional information. 2. See Note 12 for additional information. 3. Presented net of current portion of unamortized debt issuance costs. Maturities of Long-Term Debt for Next Five Years at Mar 31, 2024 In millions 2024 $ 92 2025 $ 520 2026 $ 121 2027 $ 1,240 2028 $ 688 2029 $ 1,438 2024 Activity In the first quarter of 2024, the Company issued $1.25 billion of senior unsecured notes. The offering included $600 million aggregate principal amount of 5.15 percent notes due 2034 and $650 million aggregate principal amount of 5.60 percent notes due 2054. The issuance was completed under the Company's Green Finance Framework. The Company will distribute the proceeds toward projects that support the execution of its sustainability strategy and achieve its targets focused on climate protection and a circular economy, including applicable expenditures and investments related to the Company's Fort Saskatchewan Path2Zero project. In the first quarter of 2024, the Company issued an aggregate principal amount of $9 million of InterNotes ® . The Company also issued $122 million of foreign currency loans. Additionally, the Company repaid $63 million of long-term debt. Available Credit Facilities The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Mar 31, 2024 In millions Committed Credit Available Credit Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 November 2028 Floating rate Bilateral Revolving Credit Facility 375 375 October 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 200 200 September 2025 Floating rate Bilateral Revolving Credit Facility 175 175 September 2025 Floating rate Bilateral Revolving Credit Facility 300 300 November 2025 Floating rate Bilateral Revolving Credit Facility 300 300 February 2026 Floating rate Bilateral Revolving Credit Facility 100 100 March 2026 Floating rate Bilateral Revolving Credit Facility 150 150 November 2026 Floating rate Bilateral Revolving Credit Facility 200 200 November 2026 Floating rate Bilateral Revolving Credit Facility 250 250 March 2027 Floating rate Bilateral Revolving Credit Facility 100 100 May 2027 Floating rate Bilateral Revolving Credit Facility 350 350 June 2027 Floating rate Bilateral Revolving Credit Facility 200 200 September 2027 Floating rate Bilateral Revolving Credit Facility 100 100 October 2027 Floating rate Bilateral Revolving Credit Facility 100 100 November 2027 Floating rate Bilateral Revolving Credit Facility 300 300 May 2028 Floating rate Total committed and available credit facilities $ 8,400 $ 8,400 Debt Covenants and Default Provisions There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first three months of 2024. For additional information on the Company's debt covenants and default provisions, see Note 13 to the Consolidated Financial Statements included in the 2023 10-K.

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Notes)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure	COMMITMENTS AND CONTINGENCIES A summary of the Company's commitments and contingencies can be found in Note 14 to the Consolidated Financial Statements included in the 2023 10-K, which is incorporated by reference herein. Environmental Matters Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At March 31, 2024, the Company had accrued obligations of $1,170 million for probable environmental remediation and restoration costs ($1,180 million at December 31, 2023), including $243 million for the remediation of Superfund sites ($241 million at December 31, 2023). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability. Litigation Asbestos-Related Matters of Union Carbide Corporation Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2024 activity, it was determined that no adjustment to the accrual was required at March 31, 2024. Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $844 million at March 31, 2024 ($867 million at December 31, 2023). At March 31, 2024, approximately 25 percent of the recorded claim liability related to pending claims and approximately 75 percent related to future claims. Groundwater Contamination The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Legacy Liabilities"). The costs associated with these Legacy Liabilities were previously covered by insurance policies that have since been depleted. In the first quarter of 2023, the Company completed a study of the Legacy Liabilities now deemed to be probable and estimable based on the public reporting of sampling data and historical information to develop a reasonable estimate of the cost of pending and future claims. As a result, the Company recorded a pretax charge of $177 million, included in "Cost of sales" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure. At March 31, 2024, the total liability related to such alleged Legacy Liabilities settlements was $162 million ($232 million at December 31, 2023), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets. The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at March 31, 2024. Indemnifications with Corning Incorporated The Company had indemnification assets with Corning Incorporated of $41 million at March 31, 2024 ($100 million at December 31, 2023) related to the 2016 ownership restructure of Dow Silicones, which were included in "Other current assets" and "Noncurrent receivables" in the consolidated balance sheets. Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter As a result of a 2019 damages judgment related to the ethylene asset matter, Nova was ordered to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars), for which the Company received payment in October 2019 and March 2020. At March 31, 2024, $201 million ($201 million at December 31, 2023) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment. Guarantees The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2024 Dec 31, 2023 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments 1 Recorded Liability Guarantees 2038 $ 1,643 $ 191 2038 $ 1,385 $ 196 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $334 million at March 31, 2024 ($298 million at December 31, 2023). The Company does not expect to be required to perform under the guarantees. Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than 1 year to 14 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote. The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is $405 million at March 31, 2024 ($150 million at December 31, 2023). The Company expects receivable collections and remittances to occur within the next six months. TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.

LEASES (Notes)

LEASES (Notes)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Lessee, Operating And Finance Leases	LEASES For additional information on the Company's leases, see Note 15 to the Consolidated Financial Statements included in the 2023 10-K. The components of lease cost for operating and finance leases for the three months ended March 31, 2024 and 2023 were as follows: Lease Cost Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Operating lease cost $ 107 $ 98 Finance lease cost Amortization of right-of-use assets - finance $ 27 $ 26 Interest on lease liabilities - finance 10 8 Total finance lease cost $ 37 $ 34 Short-term lease cost 74 66 Variable lease cost 258 181 Sublease income (2) (2) Total lease cost $ 474 $ 377 The following table provides supplemental cash flow and other information related to leases: Other Lease Information Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 116 $ 105 Operating cash flows for finance leases $ 10 $ 8 Financing cash flows for finance leases $ 30 $ 28 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 100 $ 99 Finance leases $ 70 $ 6

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss (Notes)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Comprehensive Income (Loss) Note	ACCUMULATED OTHER COMPREHENSIVE LOSS The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2024 and 2023 were as follows: Accumulated Other Comprehensive Loss Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Unrealized Gains (Losses) on Investments Beginning balance $ (253) $ (253) Unrealized gains (losses) on investments 15 30 Tax (expense) benefit (18) — Net unrealized gains (losses) on investments (3) 30 (Gains) losses reclassified from AOCL to net income 1 (4) 1 Tax expense (benefit) 2 1 — Net (gains) losses reclassified from AOCL to net income (3) 1 Other comprehensive income (loss), net of tax (6) 31 Ending balance $ (259) $ (222) Cumulative Translation Adjustment Beginning balance $ (1,891) $ (1,934) Gains (losses) on foreign currency translation (116) 84 Tax (expense) benefit (3) 2 Net gains (losses) on foreign currency translation (119) 86 (Gains) losses reclassified from AOCL to net income 3 (3) 15 Other comprehensive income (loss), net of tax (122) 101 Ending balance $ (2,013) $ (1,833) Pension and Other Postretirement Benefits Beginning balance $ (5,486) $ (4,877) Gains (losses) arising during the period (1) 2 Amortization of net loss and prior service credits reclassified from AOCL to net income 4 22 3 Tax expense (benefit) 2 (4) 1 Net loss and prior service credits reclassified from AOCL to net income 18 4 Other comprehensive income (loss), net of tax 17 6 Ending balance $ (5,469) $ (4,871) Derivative Instruments Beginning balance $ (51) $ (75) Gains (losses) on derivative instruments (33) (183) Tax (expense) benefit 3 33 Net gains (losses) on derivative instruments (30) (150) (Gains) losses reclassified from AOCL to net income 5 10 109 Tax expense (benefit) 2 (2) (23) Net (gains) losses reclassified from AOCL to net income 8 86 Other comprehensive income (loss), net of tax (22) (64) Ending balance $ (73) $ (139) Total AOCL ending balance $ (7,814) $ (7,065) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Credit for income taxes." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 15 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
Stockholders' Equity Note Disclosure [Text Block]	The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2024 and 2023 were as follows: Accumulated Other Comprehensive Loss Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Unrealized Gains (Losses) on Investments Beginning balance $ (253) $ (253) Unrealized gains (losses) on investments 15 30 Tax (expense) benefit (18) — Net unrealized gains (losses) on investments (3) 30 (Gains) losses reclassified from AOCL to net income 1 (4) 1 Tax expense (benefit) 2 1 — Net (gains) losses reclassified from AOCL to net income (3) 1 Other comprehensive income (loss), net of tax (6) 31 Ending balance $ (259) $ (222) Cumulative Translation Adjustment Beginning balance $ (1,891) $ (1,934) Gains (losses) on foreign currency translation (116) 84 Tax (expense) benefit (3) 2 Net gains (losses) on foreign currency translation (119) 86 (Gains) losses reclassified from AOCL to net income 3 (3) 15 Other comprehensive income (loss), net of tax (122) 101 Ending balance $ (2,013) $ (1,833) Pension and Other Postretirement Benefits Beginning balance $ (5,486) $ (4,877) Gains (losses) arising during the period (1) 2 Amortization of net loss and prior service credits reclassified from AOCL to net income 4 22 3 Tax expense (benefit) 2 (4) 1 Net loss and prior service credits reclassified from AOCL to net income 18 4 Other comprehensive income (loss), net of tax 17 6 Ending balance $ (5,469) $ (4,871) Derivative Instruments Beginning balance $ (51) $ (75) Gains (losses) on derivative instruments (33) (183) Tax (expense) benefit 3 33 Net gains (losses) on derivative instruments (30) (150) (Gains) losses reclassified from AOCL to net income 5 10 109 Tax expense (benefit) 2 (2) (23) Net (gains) losses reclassified from AOCL to net income 8 86 Other comprehensive income (loss), net of tax (22) (64) Ending balance $ (73) $ (139) Total AOCL ending balance $ (7,814) $ (7,065) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Credit for income taxes." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 15 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS Noncon

NONCONTROLLING INTERESTS Noncontrolling Interests	3 Months Ended
	Mar. 31, 2024
Noncontrolling Interest [Abstract]
Noncontrolling Interest Disclosure [Text Block]	NONCONTROLLING INTERESTS Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income. The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2024 and 2023: Noncontrolling Interests Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Balance at beginning of period $ 501 $ 529 Net income attributable to noncontrolling interests 22 20 Distributions to noncontrolling interests (14) (13) Cumulative translation adjustments (16) (3) Other (1) 1 Balance at end of period $ 492 $ 534

PENSION PLANS AND OTHER POSTRET

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS	3 Months Ended
	Mar. 31, 2024
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS A summary of the Company's pension and other postretirement benefit plans can be found in Note 18 to the Consolidated Financial Statements included in the 2023 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans: Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Defined Benefit Pension Plans Service cost $ 14 $ 70 Interest cost 252 279 Expected return on plan assets (346) (389) Amortization of prior service credit (3) (7) Amortization of net loss 35 24 Net periodic benefit credit $ (48) $ (23) Other Postretirement Benefit Plans Service cost $ 1 $ 1 Interest cost 11 11 Amortization of net gain (10) (14) Net periodic benefit cost (credit) $ 2 $ (2) Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement [Text Block]	STOCK-BASED COMPENSATION A summary of the Company's stock-based compensation plans can be found in Note 19 to the Consolidated Financial Statements included in the 2023 10-K. Stock Incentive Plan The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year. In the first quarter of 2024, Dow Inc. granted the following stock-based compensation awards to employees: • 1.3 million stock options with a weighted-average exercise price of $55.17 per share and a weighted-average fair value of $10.94 per share; • 2.0 million restricted stock units with a weighted-average fair value of $55.18 per share; and • 1.4 million performance stock units with a weighted-average fair value of $58.42 per share. Employee Stock Purchase Plan The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2024 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at April 1, 2024 (beginning) or October 4, 2024 (ending) of the offering period, whichever is lower. In the first quarter of 2024, employees subscribed to the right to purchase approximately 2.5 million shares under the 2021 ESPP. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2024. The shares will be delivered to employees in the fourth quarter of 2024.

Financial Instruments (Notes)

Financial Instruments (Notes)	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Financial Instruments	FINANCIAL INSTRUMENTS A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 20 to the Consolidated Financial Statements included in the 2023 10-K. Refer to Note 18 for a summary of the fair value of financial instruments at March 31, 2024 and December 31, 2023. Debt Securities The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the three months ended March 31, 2024 and 2023: Investing Results Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Proceeds from sales of available-for-sale securities $ 721 $ 146 Gross realized gains $ 9 $ 8 Gross realized losses $ (5) $ (9) The following table summarizes contractual maturities of the Company's investments in debt securities: Contractual Maturities of Debt Securities at Mar 31, 2024 Cost Fair Value In millions Within one year $ 69 $ 65 One to five years 1,233 1,132 Six to ten years 441 405 After ten years 505 414 Total $ 2,248 $ 2,016 Equity Securities There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended March 31, 2024. There were no unrealized gains or losses recognized in earnings on equity securities for the three months ended March 31, 2024 ($8 million of net unrealized gains for the three months ended March 31, 2023). Investments in Equity Securities Mar 31, 2024 Dec 31, 2023 In millions Readily determinable fair value $ 14 $ 17 Not readily determinable fair value $ 169 $ 171 Derivative Instruments The notional amounts of the Company's derivative instruments at March 31, 2024 and December 31, 2023 were as follows: Notional Amounts 1 Mar 31, 2024 Dec 31, 2023 In millions Derivatives designated as hedging instruments: Interest rate contracts $ 3,000 $ 3,000 Foreign currency contracts $ 5,190 $ 2,316 Derivatives not designated as hedging instruments: Interest rate contracts $ 38 $ 59 Foreign currency contracts $ 12,645 $ 5,824 1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration. The notional amounts of the Company's commodity derivatives at March 31, 2024 and December 31, 2023 were as follows: Commodity Notionals 1 Mar 31, 2024 Dec 31, 2023 Notional Volume Unit Derivatives designated as hedging instruments: Hydrocarbon derivatives 1.8 3.7 million barrels of oil equivalent Derivatives not designated as hedging instruments: Hydrocarbon derivatives 1.8 1.4 million barrels of oil equivalent 1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period. Maturity Dates of Derivatives Designated as Hedging Instruments Year Interest rate contracts 2025 Foreign currency contracts 2026 Commodity contracts 2026 The following table provides the fair value and balance sheet classification of derivative instruments at March 31, 2024 and December 31, 2023: Fair Value of Derivative Instruments Mar 31, 2024 Dec 31, 2023 In millions Gross Counterparty and Cash Collateral Netting 1 Net 2 Gross Counterparty and Cash Collateral Netting 1 Net 2 Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts 3 $ 47 $ (47) $ — $ 73 $ (73) $ — Interest rate contracts 4 — — — 59 (56) 3 Foreign currency contracts 3 39 (19) 20 21 (5) 16 Foreign currency contracts 4 — — — 5 — 5 Commodity contracts 3 24 (9) 15 27 (21) 6 Commodity contracts 4 3 (1) 2 2 (1) 1 Total $ 113 $ (76) $ 37 $ 187 $ (156) $ 31 Derivatives not designated as hedging instruments: Interest rate contracts 3 $ 1 $ (1) $ — $ 4 $ (3) $ 1 Foreign currency contracts 3 21 (9) 12 33 (16) 17 Commodity contracts 3 23 (8) 15 33 (28) 5 Commodity contracts 4 3 — 3 — — — Total $ 48 $ (18) $ 30 $ 70 $ (47) $ 23 Total asset derivatives $ 161 $ (94) $ 67 $ 257 $ (203) $ 54 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts 5 $ 123 $ (47) $ 76 $ 95 $ (73) $ 22 Interest rate contracts 6 — — — 56 (56) — Foreign currency contracts 5 26 (19) 7 8 (5) 3 Foreign currency contracts 6 12 — 12 — — — Commodity contracts 5 10 (9) 1 34 (22) 12 Commodity contracts 6 1 (1) — 2 (1) 1 Total $ 172 $ (76) $ 96 $ 195 $ (157) $ 38 Derivatives not designated as hedging instruments: Interest rate contracts 5 $ 1 $ (1) $ — $ 3 $ (3) $ — Foreign currency contracts 5 13 (9) 4 38 (16) 22 Commodity contracts 5 25 (10) 15 34 (28) 6 Total $ 39 $ (20) $ 19 $ 75 $ (47) $ 28 Total liability derivatives $ 211 $ (96) $ 115 $ 270 $ (204) $ 66 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. 2. Represents the net amounts included in the consolidated balance sheets. 3. Included in "Other current assets" in the consolidated balance sheets. 4. Included in "Deferred charges and other assets" in the consolidated balance sheets. 5. Included in "Accrued and other current liabilities" in the consolidated balance sheets. 6. Included in "Other noncurrent obligations" in the consolidated balance sheets. Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $21 million at March 31, 2024 ( $22 million at December 31, 2023). There was zero cash collateral posted by counterparties with the Company at March 31, 2024 and December 31, 2023. The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three months ended March 31, 2024 and 2023: Effect of Derivative Instruments Gain (loss) recognized in OCI 1 Gain (loss) recognized in income 2 Three Months Ended Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Mar 31, 2024 Mar 31, 2023 Derivatives designated as hedging instruments: Fair value hedges: Excluded components 3, 4 $ (38) $ (1) $ — $ — Cash flow hedges: Interest rate contracts 4 1 5 (2) (2) Foreign currency contracts 5 (13) — 1 2 Commodity contracts 5 15 (143) (8) (109) Excluded components 3, 5 (6) — (1) — Net foreign investment hedges: Foreign currency contracts 2 (9) — — Excluded components 3, 6 6 3 3 — Total derivatives designated as hedging instruments $ (33) $ (145) $ (7) $ (109) Derivatives not designated as hedging instruments: Interest rate contracts 4 $ — $ — $ — $ — Foreign currency contracts 6 — — 31 35 Commodity contracts 5 — — 8 — Total return swap 5 — — 22 (7) Total derivatives not designated as hedging instruments $ — $ — $ 61 $ 28 Total derivatives $ (33) $ (145) $ 54 $ (81) 1. OCI is defined as other comprehensive income (loss). 2. Pretax amounts. 3. The excluded components are related to the time value of the derivatives designated as hedges. 4. Included in "Interest expense and amortization of debt discount" in the consolidated statements of income. 5. Included in "Cost of sales" in the consolidated statements of income. 6. Included in "Sundry income (expense) - net" in the consolidated statements of income. The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months: Expected Reclassifications from AOCL within the next 12 months Mar 31, 2024 In millions Cash flow hedges: Interest rate contracts $ (4) Commodity contracts $ 9 Foreign currency contracts $ 4 Excluded components $ (5) Net foreign investment hedges: Excluded components $ 6

FAIR VALUE MEASUREMENTS (Notes)

FAIR VALUE MEASUREMENTS (Notes)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 21 to the Consolidated Financial Statements included in the 2023 10-K. Fair Value Measurements on a Recurring Basis The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Fair Value Measurements on a Recurring Basis Mar 31, 2024 Dec 31, 2023 In millions Fair Value Level Cost Gain Loss Fair Value Cost Gain Loss Fair Value Assets at fair value: Cash equivalents: Held-to-maturity securities 1 Level 2 $ 789 $ — $ — $ 789 $ 485 $ — $ — $ 485 Money market funds Level 2 689 — — 689 663 — — 663 Marketable securities 2 Level 2 837 — (66) 771 1,361 — (61) 1,300 Nonconsolidated affiliates 3 Level 3 — 7 Other investments: Debt securities: 4 Government debt 5 Level 2 914 2 (109) 807 766 3 (107) 662 Corporate bonds Level 1 20 — (2) 18 24 — (3) 21 Corporate bonds Level 2 1,114 16 (102) 1,028 1,148 17 (99) 1,066 Corporate bonds Level 3 200 — (37) 163 200 — (89) 111 Equity securities 4, 6 Level 1 4 10 — 14 5 12 — 17 Derivatives relating to: 7 Interest rates Level 2 — 48 — 48 — 136 — 136 Foreign currency Level 2 — 60 — 60 — 59 — 59 Commodities Level 1 — 2 — 2 — 2 — 2 Commodities Level 2 — 51 — 51 — 60 — 60 Total assets at fair value $ 4,440 $ 4,589 Liabilities at fair value: Long-term debt including debt due within one year 8 Level 2 $ (16,288) $ 1,311 $ (581) $ (15,558) $ (15,024) $ 1,089 $ (747) $ (14,682) Guarantee liability 9 Level 3 (172) (178) Derivatives relating to: 7 Interest rates Level 2 — — (124) (124) — — (154) (154) Foreign currency Level 2 — — (51) (51) — — (46) (46) Commodities Level 1 — — (3) (3) — — (2) (2) Commodities Level 2 — — (33) (33) — — (68) (68) Total liabilities at fair value $ (15,941) $ (15,130) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets. 3. Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets. 4. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets. 5. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 6. Equity securities with a readily determinable fair value. 7. See Note 17 for classification of derivatives in the consolidated balance sheets. 8. Cost includes fair value hedge adjustment gains of $42 million at March 31, 2024 and $49 million at December 31, 2023 on $4,479 million of debt at March 31, 2024 and December 31, 2023. 9. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets. Cost approximates fair value for all other financial instruments. For equity securities calculated at net asset value per share (or its equivalent), the Company had $85 million in private market securities and $17 million in real estate at March 31, 2024 ($86 million in private market securities and $18 million in real estate at December 31, 2023). There are no redemption restrictions and the unfunded commitments on these investments were $75 million at March 31, 2024 and December 31, 2023. For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security. At December 31, 2023, the level 3 asset values also included an investment in a limited liability company, accounted for as an investment in nonconsolidated affiliates, and with no unfunded commitment. For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara. Fair Value Measurements on a Nonrecurring Basis In the first quarter of 2024, the Company recognized impairment charges of $37 million related primarily to write-downs of certain manufacturing assets in the U.S. & Canada and EMEAI. The assets, classified as Level 3 measurements, were valued at $60 million using unobservable inputs. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. In the first quarter of 2024, as part of the 2023 Restructuring Program, the Company recorded impairment charges of $8 million for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

SEGMENTS AND GEOGRAPHIC REGIONS

SEGMENTS AND GEOGRAPHIC REGIONS (Notes)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segments and Geographic Regions [Text Block]	SEGMENTS AND GEOGRAPHIC REGIONS Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Three months ended Mar 31, 2024 Net sales $ 5,430 $ 3,008 $ 2,152 $ 175 $ 10,765 Equity in earnings (losses) of nonconsolidated affiliates $ 25 $ (15) $ 6 $ 1 $ 17 Dow Inc. Operating EBIT 1 $ 605 $ 87 $ 41 $ (59) $ 674 Three months ended Mar 31, 2023 Net sales $ 6,114 $ 3,378 $ 2,276 $ 83 $ 11,851 Equity in earnings (losses) of nonconsolidated affiliates $ 21 $ (73) $ 3 $ 1 $ (48) Dow Inc. Operating EBIT 1 $ 642 $ 123 $ 35 $ (92) $ 708 1. Operating EBIT for TDCC for the three months ended March 31, 2024 and 2023 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table. Reconciliation of "Net income (loss)" to Operating EBIT Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Net income (loss) $ 538 $ (73) + Credit for income taxes (89) (47) Income (loss) before income taxes $ 449 $ (120) - Interest income 65 76 + Interest expense and amortization of debt discount 199 185 - Significant items (91) (719) Operating EBIT $ 674 $ 708 The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT: Significant Items by Segment Three Months Ended Mar 31, 2024 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Restructuring, implementation and efficiency costs, and asset related charges - net 1 $ (37) $ (8) $ — $ (46) $ (91) Total $ (37) $ (8) $ — $ (46) $ (91) 1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets. See Note 4 for additional information. Significant Items by Segment Three Months Ended Mar 31, 2023 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Restructuring, implementation and efficiency costs, and asset related charges - net 1 $ (1) $ (40) $ (67) $ (443) (551) Litigation related charges, awards and adjustments 2 — (177) — — (177) Indemnification and other transactions related costs 3 — — — 9 9 Total $ (1) $ (217) $ (67) $ (434) $ (719) 1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes certain gains and losses associated with previously impaired equity investments. 2. Includes a loss associated with legacy agricultural products groundwater contamination matters. See Note 11 for additional information. 3. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

REVENUE (Tables)

REVENUE (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	Disaggregation of Revenue The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below: Net Trade Sales by Segment and Business Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Hydrocarbons & Energy $ 1,467 $ 1,874 Packaging and Specialty Plastics 3,963 4,240 Packaging & Specialty Plastics $ 5,430 $ 6,114 Industrial Solutions $ 1,028 $ 1,139 Polyurethanes & Construction Chemicals 1,977 2,234 Other 3 5 Industrial Intermediates & Infrastructure $ 3,008 $ 3,378 Coatings & Performance Monomers $ 885 $ 858 Consumer Solutions 1,267 1,418 Performance Materials & Coatings $ 2,152 $ 2,276 Corporate $ 175 $ 83 Total $ 10,765 $ 11,851 Net Trade Sales by Geographic Region Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 U.S. & Canada $ 4,130 $ 4,450 EMEAI 1 3,484 4,053 Asia Pacific 1,921 2,047 Latin America 1,230 1,301 Total $ 10,765 $ 11,851 1. Europe, Middle East, Africa and India.
Contract with Customer, Asset and Liability [Table Text Block]	The following table summarizes contract assets and liabilities at March 31, 2024 and December 31, 2023: Contract Assets and Liabilities Balance Sheet Classification Mar 31, 2024 Dec 31, 2023 In millions Accounts and notes receivable - trade Accounts and notes receivable - trade $ 5,212 $ 4,718 Contract assets - current Other current assets $ 13 $ 13 Contract assets - noncurrent Deferred charges and other assets $ 4 $ 4 Contract liabilities - current Accrued and other current liabilities $ 210 $ 195 Contract liabilities - noncurrent Other noncurrent obligations $ 1,600 $ 1,642

Restructuring and Related Activ

Restructuring and Related Activities (Tables)	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The following table summarizes the activities related to the 2023 Restructuring Program, including segment information: 2023 Restructuring Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Total In millions Packaging & Specialty Plastics $ — $ 1 $ 1 Industrial Intermediates & Infrastructure — 40 40 Performance Materials & Coatings — 49 49 Corporate 344 107 451 Total restructuring charges $ 344 $ 197 $ 541 Charges against the reserve — (197) (197) Cash payments (11) — (11) Reserve balance at Mar 31, 2023 $ 333 $ — $ 333 Industrial Intermediates & Infrastructure $ — $ 8 $ 8 Total restructuring charges $ — $ 8 $ 8 Charges against the reserve — (8) (8) Cash payments (60) — (60) Reserve balance at Jun 30, 2023 $ 273 $ — $ 273 Cash payments (110) — (110) Reserve balance at Sep 30, 2023 $ 163 $ — $ 163 Industrial Intermediates & Infrastructure $ — $ 2 $ 2 Corporate — (16) (16) Total restructuring charges $ — $ (14) $ (14) Charges against the reserve — 14 14 Cash payments (41) — (41) Reserve balance at Dec 31, 2023 $ 122 $ — $ 122 Industrial Intermediates & Infrastructure $ — $ 8 $ 8 Total restructuring charges $ — $ 8 $ 8 Charges against the reserve — (8) (8) Cash payments (48) — (48) Reserve balance at Mar 31, 2024 $ 74 $ — $ 74

SUPPLEMENTARY INFORMATION (Tabl

SUPPLEMENTARY INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Sundry Income, Net	Dow Inc. Sundry Income (Expense) – Net Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Non-operating pension and other postretirement benefit plan net credits 1 $ 61 $ 96 Foreign exchange losses 2 (23) (102) Gain on sales of other assets and investments 3 9 65 Asset impairments and related costs 4 — (18) Indemnification and other transaction related costs 5 — 9 Other - net 14 29 Total sundry income (expense) – net $ 61 $ 79 1. See Note 15 for additional information. 2. Foreign exchange losses for the three months ended March 31, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso. Foreign exchange losses for the three months ended March 31, 2023 relate primarily to exposures in the Argentine peso. 3. The three months ended March 31, 2023 includes gains associated with the sale of shares of a previously impaired equity method investment. 4. Certain obligations associated with a previously impaired equity method investment. 5. Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva") as part of the separation and distribution.
Schedule of Company-Owned Life Insurance	Other Investments The Company has investments in company-owned life insurance policies ("COLI"), which are recorded at their cash surrender value as of each balance sheet date, as provided below: Investments in Company-Owned Life Insurance Mar 31, 2024 Dec 31, 2023 In millions Gross cash value $ 638 $ 623 Less: Existing drawdowns 1 198 97 Less: Accrued interest on drawdowns 2 2 — Investments in company-owned life insurance 3 $ 438 $ 526 1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows. 2. Included in "Sundry income (expense) - net" in the consolidated statements of income. 3. Classified as "Other investments" in the consolidated balance sheets.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2024 and 2023. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income (Loss) for Earnings Per Share Calculations Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Net income (loss) $ 538 $ (73) Net income attributable to noncontrolling interests 22 20 Net income attributable to participating securities 1 3 3 Net income (loss) attributable to common stockholders $ 513 $ (96) Earnings (Loss) Per Share - Basic and Diluted Three Months Ended Dollars per share Mar 31, 2024 Mar 31, 2023 Earnings (loss) per common share - basic $ 0.73 $ (0.13) Earnings (loss) per common share - diluted $ 0.73 $ (0.13) Share Count Information Three Months Ended Shares in millions Mar 31, 2024 Mar 31, 2023 Weighted-average common shares outstanding - basic 704.5 708.2 Plus dilutive effect of equity compensation plans 2 1.0 — Weighted-average common shares outstanding - diluted 705.5 708.2 Stock units excluded from EPS calculations 3 8.8 22.1 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. 2. The three months ended March 31, 2023 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis. 3. These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	The following table provides a breakdown of inventories: Inventories Mar 31, 2024 Dec 31, 2023 In millions Finished goods $ 3,741 $ 3,413 Work in process 1,318 1,234 Raw materials 767 746 Supplies 983 992 Total $ 6,809 $ 6,385 Adjustment of inventories to the LIFO basis (436) (309) Total inventories $ 6,373 $ 6,076

NOTES PAYABLE, LONG-TERM DEBT_2

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Short-term Debt	Notes Payable Mar 31, 2024 Dec 31, 2023 In millions Notes payable to banks and other lenders $ 55 $ 62 Period-end average interest rates 34.55 % 33.84 %
Schedule of Long-term Debt Instruments	Long-Term Debt 2024 Average Rate Mar 31, 2024 2023 Average Rate Dec 31, 2023 In millions Promissory notes and debentures: Final maturity 2025 5.63 % $ 333 5.63 % $ 333 Final maturity 2028 4.80 % 600 4.80 % 600 Final maturity 2029 7.58 % 1,367 7.58 % 1,367 Final maturity 2030 and thereafter 1 5.10 % 10,103 5.07 % 8,861 Other facilities: Foreign currency notes and loans, various rates and maturities 3.89 % 2,645 1.18 % 2,653 InterNotes®, varying maturities through 2054 4.14 % 595 4.12 % 595 Finance lease obligations 2 908 873 Unamortized debt discount and issuance costs (263) (258) Long-term debt due within one year 3 (118) (117) Long-term debt $ 16,170 $ 14,907 1. Cost includes net fair value hedge adjustment gains o f $42 million at March 31, 2024 ($49 million at December 31, 2023). See Note 17 for additional information. 2. See Note 12 for additional information. 3. Presented net of current portion of unamortized debt issuance costs.
Schedule of Maturities of Long-term Debt	Maturities of Long-Term Debt for Next Five Years at Mar 31, 2024 In millions 2024 $ 92 2025 $ 520 2026 $ 121 2027 $ 1,240 2028 $ 688 2029 $ 1,438
Schedule of Line of Credit Facilities	The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Mar 31, 2024 In millions Committed Credit Available Credit Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 November 2028 Floating rate Bilateral Revolving Credit Facility 375 375 October 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 200 200 September 2025 Floating rate Bilateral Revolving Credit Facility 175 175 September 2025 Floating rate Bilateral Revolving Credit Facility 300 300 November 2025 Floating rate Bilateral Revolving Credit Facility 300 300 February 2026 Floating rate Bilateral Revolving Credit Facility 100 100 March 2026 Floating rate Bilateral Revolving Credit Facility 150 150 November 2026 Floating rate Bilateral Revolving Credit Facility 200 200 November 2026 Floating rate Bilateral Revolving Credit Facility 250 250 March 2027 Floating rate Bilateral Revolving Credit Facility 100 100 May 2027 Floating rate Bilateral Revolving Credit Facility 350 350 June 2027 Floating rate Bilateral Revolving Credit Facility 200 200 September 2027 Floating rate Bilateral Revolving Credit Facility 100 100 October 2027 Floating rate Bilateral Revolving Credit Facility 100 100 November 2027 Floating rate Bilateral Revolving Credit Facility 300 300 May 2028 Floating rate Total committed and available credit facilities $ 8,400 $ 8,400

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Tables)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Table of Guarantees by Type	The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2024 Dec 31, 2023 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments 1 Recorded Liability Guarantees 2038 $ 1,643 $ 191 2038 $ 1,385 $ 196 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $334 million at March 31, 2024 ($298 million at December 31, 2023). The Company does not expect to be required to perform under the guarantees.
Schedule of Guarantor Obligations	The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees: Guarantees Mar 31, 2024 Dec 31, 2023 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments 1 Recorded Liability Guarantees 2038 $ 1,643 $ 191 2038 $ 1,385 $ 196 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $334 million at March 31, 2024 ($298 million at December 31, 2023). The Company does not expect to be required to perform under the guarantees.

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2024
Guarantor Obligations [Line Items]
Lease, Cost	The components of lease cost for operating and finance leases for the three months ended March 31, 2024 and 2023 were as follows: Lease Cost Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Operating lease cost $ 107 $ 98 Finance lease cost Amortization of right-of-use assets - finance $ 27 $ 26 Interest on lease liabilities - finance 10 8 Total finance lease cost $ 37 $ 34 Short-term lease cost 74 66 Variable lease cost 258 181 Sublease income (2) (2) Total lease cost $ 474 $ 377
Schedule of Supplemental Cash Flow Information Related to Leases	The following table provides supplemental cash flow and other information related to leases: Other Lease Information Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 116 $ 105 Operating cash flows for finance leases $ 10 $ 8 Financing cash flows for finance leases $ 30 $ 28 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 100 $ 99 Finance leases $ 70 $ 6

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2024 and 2023 were as follows: Accumulated Other Comprehensive Loss Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Unrealized Gains (Losses) on Investments Beginning balance $ (253) $ (253) Unrealized gains (losses) on investments 15 30 Tax (expense) benefit (18) — Net unrealized gains (losses) on investments (3) 30 (Gains) losses reclassified from AOCL to net income 1 (4) 1 Tax expense (benefit) 2 1 — Net (gains) losses reclassified from AOCL to net income (3) 1 Other comprehensive income (loss), net of tax (6) 31 Ending balance $ (259) $ (222) Cumulative Translation Adjustment Beginning balance $ (1,891) $ (1,934) Gains (losses) on foreign currency translation (116) 84 Tax (expense) benefit (3) 2 Net gains (losses) on foreign currency translation (119) 86 (Gains) losses reclassified from AOCL to net income 3 (3) 15 Other comprehensive income (loss), net of tax (122) 101 Ending balance $ (2,013) $ (1,833) Pension and Other Postretirement Benefits Beginning balance $ (5,486) $ (4,877) Gains (losses) arising during the period (1) 2 Amortization of net loss and prior service credits reclassified from AOCL to net income 4 22 3 Tax expense (benefit) 2 (4) 1 Net loss and prior service credits reclassified from AOCL to net income 18 4 Other comprehensive income (loss), net of tax 17 6 Ending balance $ (5,469) $ (4,871) Derivative Instruments Beginning balance $ (51) $ (75) Gains (losses) on derivative instruments (33) (183) Tax (expense) benefit 3 33 Net gains (losses) on derivative instruments (30) (150) (Gains) losses reclassified from AOCL to net income 5 10 109 Tax expense (benefit) 2 (2) (23) Net (gains) losses reclassified from AOCL to net income 8 86 Other comprehensive income (loss), net of tax (22) (64) Ending balance $ (73) $ (139) Total AOCL ending balance $ (7,814) $ (7,065) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Credit for income taxes." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 15 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS Nonc_2

NONCONTROLLING INTERESTS Noncontrolling Interests (Tables)	3 Months Ended
	Mar. 31, 2024
Noncontrolling Interest [Abstract]
Noncontrolling Interests [Table Text Block]	The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2024 and 2023: Noncontrolling Interests Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Balance at beginning of period $ 501 $ 529 Net income attributable to noncontrolling interests 22 20 Distributions to noncontrolling interests (14) (13) Cumulative translation adjustments (16) (3) Other (1) 1 Balance at end of period $ 492 $ 534

PENSION PLANS AND OTHER POSTR_2

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)	3 Months Ended
	Mar. 31, 2024
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans: Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Defined Benefit Pension Plans Service cost $ 14 $ 70 Interest cost 252 279 Expected return on plan assets (346) (389) Amortization of prior service credit (3) (7) Amortization of net loss 35 24 Net periodic benefit credit $ (48) $ (23) Other Postretirement Benefit Plans Service cost $ 1 $ 1 Interest cost 11 11 Amortization of net gain (10) (14) Net periodic benefit cost (credit) $ 2 $ (2)

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investing Results	The following table provides investing results from available-for-sale securities for the three months ended March 31, 2024 and 2023: Investing Results Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Proceeds from sales of available-for-sale securities $ 721 $ 146 Gross realized gains $ 9 $ 8 Gross realized losses $ (5) $ (9)
Contractual Maturities of Debt Securities	The following table summarizes contractual maturities of the Company's investments in debt securities: Contractual Maturities of Debt Securities at Mar 31, 2024 Cost Fair Value In millions Within one year $ 69 $ 65 One to five years 1,233 1,132 Six to ten years 441 405 After ten years 505 414 Total $ 2,248 $ 2,016
Equity Securities with and without Readily Determinable Fair Value	Investments in Equity Securities Mar 31, 2024 Dec 31, 2023 In millions Readily determinable fair value $ 14 $ 17 Not readily determinable fair value $ 169 $ 171
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts of the Company's derivative instruments at March 31, 2024 and December 31, 2023 were as follows: Notional Amounts 1 Mar 31, 2024 Dec 31, 2023 In millions Derivatives designated as hedging instruments: Interest rate contracts $ 3,000 $ 3,000 Foreign currency contracts $ 5,190 $ 2,316 Derivatives not designated as hedging instruments: Interest rate contracts $ 38 $ 59 Foreign currency contracts $ 12,645 $ 5,824 1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration. The notional amounts of the Company's commodity derivatives at March 31, 2024 and December 31, 2023 were as follows: Commodity Notionals 1 Mar 31, 2024 Dec 31, 2023 Notional Volume Unit Derivatives designated as hedging instruments: Hydrocarbon derivatives 1.8 3.7 million barrels of oil equivalent Derivatives not designated as hedging instruments: Hydrocarbon derivatives 1.8 1.4 million barrels of oil equivalent 1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
Schedule of Derivative Instruments	Maturity Dates of Derivatives Designated as Hedging Instruments Year Interest rate contracts 2025 Foreign currency contracts 2026 Commodity contracts 2026
Schedule of Fair Values of Derivative Instruments	The following table provides the fair value and balance sheet classification of derivative instruments at March 31, 2024 and December 31, 2023: Fair Value of Derivative Instruments Mar 31, 2024 Dec 31, 2023 In millions Gross Counterparty and Cash Collateral Netting 1 Net 2 Gross Counterparty and Cash Collateral Netting 1 Net 2 Asset derivatives Derivatives designated as hedging instruments: Interest rate contracts 3 $ 47 $ (47) $ — $ 73 $ (73) $ — Interest rate contracts 4 — — — 59 (56) 3 Foreign currency contracts 3 39 (19) 20 21 (5) 16 Foreign currency contracts 4 — — — 5 — 5 Commodity contracts 3 24 (9) 15 27 (21) 6 Commodity contracts 4 3 (1) 2 2 (1) 1 Total $ 113 $ (76) $ 37 $ 187 $ (156) $ 31 Derivatives not designated as hedging instruments: Interest rate contracts 3 $ 1 $ (1) $ — $ 4 $ (3) $ 1 Foreign currency contracts 3 21 (9) 12 33 (16) 17 Commodity contracts 3 23 (8) 15 33 (28) 5 Commodity contracts 4 3 — 3 — — — Total $ 48 $ (18) $ 30 $ 70 $ (47) $ 23 Total asset derivatives $ 161 $ (94) $ 67 $ 257 $ (203) $ 54 Liability derivatives Derivatives designated as hedging instruments: Interest rate contracts 5 $ 123 $ (47) $ 76 $ 95 $ (73) $ 22 Interest rate contracts 6 — — — 56 (56) — Foreign currency contracts 5 26 (19) 7 8 (5) 3 Foreign currency contracts 6 12 — 12 — — — Commodity contracts 5 10 (9) 1 34 (22) 12 Commodity contracts 6 1 (1) — 2 (1) 1 Total $ 172 $ (76) $ 96 $ 195 $ (157) $ 38 Derivatives not designated as hedging instruments: Interest rate contracts 5 $ 1 $ (1) $ — $ 3 $ (3) $ — Foreign currency contracts 5 13 (9) 4 38 (16) 22 Commodity contracts 5 25 (10) 15 34 (28) 6 Total $ 39 $ (20) $ 19 $ 75 $ (47) $ 28 Total liability derivatives $ 211 $ (96) $ 115 $ 270 $ (204) $ 66 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. 2. Represents the net amounts included in the consolidated balance sheets. 3. Included in "Other current assets" in the consolidated balance sheets. 4. Included in "Deferred charges and other assets" in the consolidated balance sheets. 5. Included in "Accrued and other current liabilities" in the consolidated balance sheets. 6. Included in "Other noncurrent obligations" in the consolidated balance sheets.
Derivative Instruments, Gain (Loss)	The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three months ended March 31, 2024 and 2023: Effect of Derivative Instruments Gain (loss) recognized in OCI 1 Gain (loss) recognized in income 2 Three Months Ended Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Mar 31, 2024 Mar 31, 2023 Derivatives designated as hedging instruments: Fair value hedges: Excluded components 3, 4 $ (38) $ (1) $ — $ — Cash flow hedges: Interest rate contracts 4 1 5 (2) (2) Foreign currency contracts 5 (13) — 1 2 Commodity contracts 5 15 (143) (8) (109) Excluded components 3, 5 (6) — (1) — Net foreign investment hedges: Foreign currency contracts 2 (9) — — Excluded components 3, 6 6 3 3 — Total derivatives designated as hedging instruments $ (33) $ (145) $ (7) $ (109) Derivatives not designated as hedging instruments: Interest rate contracts 4 $ — $ — $ — $ — Foreign currency contracts 6 — — 31 35 Commodity contracts 5 — — 8 — Total return swap 5 — — 22 (7) Total derivatives not designated as hedging instruments $ — $ — $ 61 $ 28 Total derivatives $ (33) $ (145) $ 54 $ (81) 1. OCI is defined as other comprehensive income (loss). 2. Pretax amounts. 3. The excluded components are related to the time value of the derivatives designated as hedges. 4. Included in "Interest expense and amortization of debt discount" in the consolidated statements of income. 5. Included in "Cost of sales" in the consolidated statements of income. 6. Included in "Sundry income (expense) - net" in the consolidated statements of income.
Schedule of Hedging Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized Over Next Fiscal Year	The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months: Expected Reclassifications from AOCL within the next 12 months Mar 31, 2024 In millions Cash flow hedges: Interest rate contracts $ (4) Commodity contracts $ 9 Foreign currency contracts $ 4 Excluded components $ (5) Net foreign investment hedges: Excluded components $ 6

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Fair Value Measurements on a Recurring Basis Mar 31, 2024 Dec 31, 2023 In millions Fair Value Level Cost Gain Loss Fair Value Cost Gain Loss Fair Value Assets at fair value: Cash equivalents: Held-to-maturity securities 1 Level 2 $ 789 $ — $ — $ 789 $ 485 $ — $ — $ 485 Money market funds Level 2 689 — — 689 663 — — 663 Marketable securities 2 Level 2 837 — (66) 771 1,361 — (61) 1,300 Nonconsolidated affiliates 3 Level 3 — 7 Other investments: Debt securities: 4 Government debt 5 Level 2 914 2 (109) 807 766 3 (107) 662 Corporate bonds Level 1 20 — (2) 18 24 — (3) 21 Corporate bonds Level 2 1,114 16 (102) 1,028 1,148 17 (99) 1,066 Corporate bonds Level 3 200 — (37) 163 200 — (89) 111 Equity securities 4, 6 Level 1 4 10 — 14 5 12 — 17 Derivatives relating to: 7 Interest rates Level 2 — 48 — 48 — 136 — 136 Foreign currency Level 2 — 60 — 60 — 59 — 59 Commodities Level 1 — 2 — 2 — 2 — 2 Commodities Level 2 — 51 — 51 — 60 — 60 Total assets at fair value $ 4,440 $ 4,589 Liabilities at fair value: Long-term debt including debt due within one year 8 Level 2 $ (16,288) $ 1,311 $ (581) $ (15,558) $ (15,024) $ 1,089 $ (747) $ (14,682) Guarantee liability 9 Level 3 (172) (178) Derivatives relating to: 7 Interest rates Level 2 — — (124) (124) — — (154) (154) Foreign currency Level 2 — — (51) (51) — — (46) (46) Commodities Level 1 — — (3) (3) — — (2) (2) Commodities Level 2 — — (33) (33) — — (68) (68) Total liabilities at fair value $ (15,941) $ (15,130) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets. 3. Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets. 4. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets. 5. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 6. Equity securities with a readily determinable fair value. 7. See Note 17 for classification of derivatives in the consolidated balance sheets. 8. Cost includes fair value hedge adjustment gains of $42 million at March 31, 2024 and $49 million at December 31, 2023 on $4,479 million of debt at March 31, 2024 and December 31, 2023. 9. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

SEGMENTS AND GEOGRAPHIC REGIO_2

SEGMENTS AND GEOGRAPHIC REGIONS (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Three months ended Mar 31, 2024 Net sales $ 5,430 $ 3,008 $ 2,152 $ 175 $ 10,765 Equity in earnings (losses) of nonconsolidated affiliates $ 25 $ (15) $ 6 $ 1 $ 17 Dow Inc. Operating EBIT 1 $ 605 $ 87 $ 41 $ (59) $ 674 Three months ended Mar 31, 2023 Net sales $ 6,114 $ 3,378 $ 2,276 $ 83 $ 11,851 Equity in earnings (losses) of nonconsolidated affiliates $ 21 $ (73) $ 3 $ 1 $ (48) Dow Inc. Operating EBIT 1 $ 642 $ 123 $ 35 $ (92) $ 708 1. Operating EBIT for TDCC for the three months ended March 31, 2024 and 2023 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table.
Reconciliation of income from continuing operations, net of tax to Operating EBIT [Table Text Block]	Reconciliation of "Net income (loss)" to Operating EBIT Three Months Ended In millions Mar 31, 2024 Mar 31, 2023 Net income (loss) $ 538 $ (73) + Credit for income taxes (89) (47) Income (loss) before income taxes $ 449 $ (120) - Interest income 65 76 + Interest expense and amortization of debt discount 199 185 - Significant items (91) (719) Operating EBIT $ 674 $ 708
Schedule of significant items [Table Text Block]	The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT: Significant Items by Segment Three Months Ended Mar 31, 2024 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Restructuring, implementation and efficiency costs, and asset related charges - net 1 $ (37) $ (8) $ — $ (46) $ (91) Total $ (37) $ (8) $ — $ (46) $ (91) 1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets. See Note 4 for additional information. Significant Items by Segment Three Months Ended Mar 31, 2023 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Mat. & Coatings Corp. Total In millions Restructuring, implementation and efficiency costs, and asset related charges - net 1 $ (1) $ (40) $ (67) $ (443) (551) Litigation related charges, awards and adjustments 2 — (177) — — (177) Indemnification and other transactions related costs 3 — — — 9 9 Total $ (1) $ (217) $ (67) $ (434) $ (719) 1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes certain gains and losses associated with previously impaired equity investments. 2. Includes a loss associated with legacy agricultural products groundwater contamination matters. See Note 11 for additional information. 3. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

REVENUE (Details)

REVENUE (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenue from External Customer [Line Items]
Revenue, Percentage from Products and Service Transferred to Customers	98%	99%
Revenue, Remaining Performance Obligation, Amount	$ 743		$ 744
Revenues	10,765	$ 11,851
Contract with Customer, Liability, Revenue Recognized	40	40
Accounts and notes receivable - Trade	5,212		4,718
Contract assets - current	13		13
Contract assets - noncurrent	4		4
Contract liabilities - current	210		195
Contract liabilities - noncurrent	1,600		1,642
The Dow Chemical Company
Revenue from External Customer [Line Items]
Accounts and notes receivable - Trade	5,212		$ 4,718
U.S. & Canada
Revenue from External Customer [Line Items]
Revenues	4,130	4,450
EMEAI 1
Revenue from External Customer [Line Items]
Revenues	3,484	4,053
Asia Pacific
Revenue from External Customer [Line Items]
Revenues	1,921	2,047
Latin America
Revenue from External Customer [Line Items]
Revenues	$ 1,230	1,301
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	20 years
Packaging & Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Revenues	$ 5,430	6,114
Packaging & Specialty Plastics [Member] | Hydrocarbons & Energy [Member]
Revenue from External Customer [Line Items]
Revenues	1,467	1,874
Packaging & Specialty Plastics [Member] | Packaging and Specialty Plastics [Member]
Revenue from External Customer [Line Items]
Revenues	3,963	4,240
Industrial Intermediates & Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenues	3,008	3,378
Industrial Intermediates & Infrastructure [Member] | Industrial Solutions [Member]
Revenue from External Customer [Line Items]
Revenues	1,028	1,139
Industrial Intermediates & Infrastructure [Member] | Polyurethanes & CAV [Member]
Revenue from External Customer [Line Items]
Revenues	1,977	2,234
Industrial Intermediates & Infrastructure [Member] | Other [Member]
Revenue from External Customer [Line Items]
Revenues	3	5
Performance Materials & Coatings [Member]
Revenue from External Customer [Line Items]
Revenues	2,152	2,276
Performance Materials & Coatings [Member] | Coatings and Performance Monomers [Member]
Revenue from External Customer [Line Items]
Revenues	885	858
Performance Materials & Coatings [Member] | Consumer Solutions [Member]
Revenue from External Customer [Line Items]
Revenues	1,267	1,418
Corporate Segment [Member]
Revenue from External Customer [Line Items]
Revenues	$ 175	$ 83

RESTRUCTURING AND ASSET RELAT_2

RESTRUCTURING AND ASSET RELATED CHARGES - NET (2023 Restructuring Program) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ (45)				$ (541)
Restructuring Charges	(91)				(551)
2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	74	$ 122	$ 163	$ 273	333
Payments for Restructuring	48	41	110	60	11
Restructuring Reserve, Settled without Cash	8	14		8	197
Restructuring and asset related charges - net	(8)	(14)		(8)	(541)
Restructuring Reserve, Settled without Cash	(8)	(14)		(8)	(197)
Restructuring Charges	543
2023 Restructuring Program | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	74	122	163	273	333
Payments for Restructuring	48	41	110	60	11
Restructuring Reserve, Settled without Cash	0	0		0	0
Restructuring and asset related charges - net	0	0		0	(344)
Restructuring Reserve, Settled without Cash	0	0		0	0
Restructuring Charges	344
2023 Restructuring Program | Asset write-downs and write-offs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	0	0	0	0	0
Payments for Restructuring	0	0	$ 0	0	0
Restructuring Reserve, Settled without Cash	8	14		8	197
Restructuring and asset related charges - net	(8)	(14)		(8)	(197)
Restructuring Reserve, Settled without Cash	(8)	(14)		(8)	(197)
Restructuring Charges	199
2023 Restructuring Program | Restructuring Implementation Costs
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	46
2023 Restructuring Program | Restructuring Implementation Costs | Additional Cash Expenditures
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	255
Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	(37)				(1)
Asset Impairment Charges	37
Packaging & Specialty Plastics [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					(1)
Packaging & Specialty Plastics [Member] | 2023 Restructuring Program | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					0
Packaging & Specialty Plastics [Member] | 2023 Restructuring Program | Asset write-downs and write-offs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					(1)
Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	(8)				(40)
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	(8)	(2)		(8)	(40)
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	0	0		0	0
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program | Asset write-downs and write-offs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	(8)	(2)		$ (8)	(40)
Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0				(67)
Performance Materials & Coatings [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					(49)
Performance Materials & Coatings [Member] | 2023 Restructuring Program | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					0
Performance Materials & Coatings [Member] | 2023 Restructuring Program | Asset write-downs and write-offs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					(49)
Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	(46)				(443)
Corporate Segment [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		(16)			(451)
Corporate Segment [Member] | 2023 Restructuring Program | Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		0			(344)
Corporate Segment [Member] | 2023 Restructuring Program | Asset write-downs and write-offs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		(16)			$ (107)
Accrued and Other Current Liabilities [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	70	101
Other Noncurrent Obligations [Member] | 2023 Restructuring Program
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	$ 4	$ 21

Summary of Sundry Income (Expen

Summary of Sundry Income (Expense) - Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Charges related to separation, distribution and tax matters agreements		$ 9
Other Nonoperating Income (Expense)	$ 14	29
Sundry income (expense) - net	61	79
Nonoperating Income (Expense)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	61	96
Foreign Currency Transaction Gain (Loss), before Tax	(23)	(102)
Gain (Loss) on Disposition of Other Assets	9	65
Restructuring Costs	0	(18)
Charges related to separation, distribution and tax matters agreements	$ 0	$ 9

Company-Owned Life Insurance (D

Company-Owned Life Insurance (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Gross Life Insurance, Corporate or Bank Owned, Amount	$ 638	$ 623
Life Insurance, Corporate or Bank Owned, Amount	438	526
COLI Monetization [Member]
Other Short-term Borrowings	198	97
Interest Payable	$ 2	$ 0

Supplier Finance Program (Detai

Supplier Finance Program (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Minimum [Member]
Supplier Finance Program, Payment Timing, Period	90 days
Maximum [Member]
Supplier Finance Program, Payment Timing, Period	120 days
Accounts Payable
Supplier Finance Program Obligation, Current	$ 291	$ 285

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Credit for income taxes	$ (89)	$ (47)
Effective Income Tax Rate Reconciliation, Percent	(19.80%)	39.20%
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	$ 194

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net income (loss)	$ 538	$ (73)
Net income attributable to noncontrolling interests	22	20
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	3	3
Net Income (Loss) Available to Common Stockholders, Basic	$ 513	$ (96)
Earnings Per Share, Basic	$ 0.73	$ (0.13)
Earnings Per Share, Diluted	$ 0.73	$ (0.13)
Weighted-average common shares outstanding - basic	704.5	708.2
Dilutive effect of equity compensation plans	1	0
Weighted-average common shares outstanding - diluted	705.5	708.2
Stock options and restricted stock units excluded from EPS calculations	8.8	22.1

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 3,741	$ 3,413
Work in process	1,318	1,234
Raw materials	767	746
Supplies	983	992
Total	6,809	6,385
Adjustment of inventories to the LIFO basis	(436)	(309)
Total inventories	$ 6,373	$ 6,076

TRANSFERS OF FINANCIAL ASSETS (

TRANSFERS OF FINANCIAL ASSETS (Details) € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 EUR (€)	Dec. 31, 2023 USD ($)
Accounts Receivable Facility, U.S.
Trade Accounts Receivable Eligible for Sale	$ 900
Accounts Receivable Facility, Europe [Member]
Trade Accounts Receivable Eligible for Sale | €			€ 500
Accounts Receivable Facility, U.S. and Europe
Cash Flows Between Transferor and Transferee, Proceeds from New Transfers	279	$ 0
Cash Flows Between Transferor and Transferee [Abstract]
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized	273			$ 79
Accounts Receivable Discounting Facility
Cash Flows Between Transferor and Transferee, Proceeds from New Transfers	148	$ 0
Cash Flows Between Transferor and Transferee [Abstract]
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized	$ 148			$ 91

NOTES PAYABLE, LONG-TERM DEBT_3

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Short-term Debt [Line Items]
Period-end average interest rates	34.55%	33.84%
Notes Payable to Banks [Member]
Short-term Debt [Line Items]
Short-term Debt	$ 55	$ 62

NOTES PAYABLE, LONG-TERM DEBT_4

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Long-Term Debt (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Unamortized debt discount and issuance costs	$ (263)	$ (258)
Long-term debt due within one year 3	(118)	(117)
Long-Term Debt	16,170	14,907
Long Term Debt, Accumulated Fair Value Adjustment	42	$ 49
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year	92
Long-Term Debt, Maturity, Year One	520
Long-term Debt, Maturities, Repayments of Principal in Year Two	121
Long-term Debt, Maturities, Repayments of Principal in Year Three	1,240
Long-term Debt, Maturities, Repayments of Principal in Year Four	688
Long-term Debt, Maturities, Repayments of Principal in Year Five	1,438
Repayments of Long-term Debt	$ 63
Senior Unsecured Notes, 5.15 Percent, Due 2034
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.15%
Debt Instrument, Face Amount	$ 600
Senior Unsecured Notes, 5.60 Percent, Due 2054
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.60%
Debt Instrument, Face Amount	$ 650
Senior Unsecured Notes
Debt Instrument [Line Items]
Debt Instrument, Face Amount	1,250
InterNotes
Debt Instrument [Line Items]
Notes Issued	9
Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 122
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Two [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time		5.63%
Long-term Debt, Gross		$ 333
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Five [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	7.58%	4.80%
Long-term Debt, Gross	$ 1,367	$ 600
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Six and Thereafter [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	5.10%
Long-term Debt, Gross	$ 10,103
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year One [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	5.63%
Long-term Debt, Gross	$ 333
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Four [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.80%
Long-term Debt, Gross	$ 600
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity,
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time		5.07%
Long-term Debt, Gross		$ 8,861
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Six
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time		7.58%
Long-term Debt, Gross		$ 1,367
Loans Payable [Member] | Foreign Currency Loans [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	3.89%	1.18%
Long-term Debt, Gross	$ 2,645	$ 2,653
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.14%	4.12%
Long-term Debt, Gross	$ 595	$ 595
Finance Leases [Member]
Debt Instrument [Line Items]
Finance lease obligations 2	$ 908	$ 873

NOTES PAYABLE, LONG-TERM DEBT_5

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Committed and Available Credit Facilities (Details) $ in Millions	Mar. 31, 2024 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 8,400
Line of Credit Facility, Remaining Borrowing Capacity	8,400
Revolving Credit Facility [Member] | Five Year Competitive Advance and Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	5,000
Line of Credit Facility, Remaining Borrowing Capacity	5,000
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2025, Facility One [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2025, Facility Two [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	200
Line of Credit Facility, Remaining Borrowing Capacity	200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2026
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2026
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	150
Line of Credit Facility, Remaining Borrowing Capacity	150
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due May 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due June 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	350
Line of Credit Facility, Remaining Borrowing Capacity	350
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	200
Line of Credit Facility, Remaining Borrowing Capacity	200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2025, Facility Two
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	175
Line of Credit Facility, Remaining Borrowing Capacity	175
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2025
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	300
Line of Credit Facility, Remaining Borrowing Capacity	300
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2026, Facility Two
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	200
Line of Credit Facility, Remaining Borrowing Capacity	200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	250
Line of Credit Facility, Remaining Borrowing Capacity	250
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due October 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	100
Line of Credit Facility, Remaining Borrowing Capacity	100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due Due May 2028
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	300
Line of Credit Facility, Remaining Borrowing Capacity	300
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due October 2024
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	375
Line of Credit Facility, Remaining Borrowing Capacity	375
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due February 2026
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	300
Line of Credit Facility, Remaining Borrowing Capacity	$ 300

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Environmental Matters) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 1,170	$ 1,180
Accrual For Environmental Loss Contingencies Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 243	$ 241

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES (Asbestos-Related Matters of Union Carbide Corporation) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Loss Contingencies [Line Items]
Liability for Asbestos and Environmental Claims, Gross	$ 844	$ 867
Percentage of recorded asbestos liability related to pending claims	25%
Percentage of recorded asbestos liability related to future claims	75%

Commitment and Contingencies (G

Commitment and Contingencies (Groundwater Contamination) (Details) - Legacy agricultural chemical prodcuts - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Product Liability Contingency [Line Items]
Product Liability Accrual, Period Expense	$ 177
Product Liability Accrual, Component Amount		$ 162	$ 232

COMMITMENTS AND CONTINGENCIES I

COMMITMENTS AND CONTINGENCIES Indemnifications with Corning (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Dow Silicones Corporation [Member]
Loss Contingencies [Line Items]
Indemnification Asset	$ 41	$ 100

COMMITMENTS AND CONTINGENCIES N

COMMITMENTS AND CONTINGENCIES Nova Ethylene Asset Matter (Details) - Nova Ethylene Asset Matter [Member] $ in Millions, $ in Millions	Sep. 18, 2019 CAD ($)	Sep. 18, 2019 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Gain Contingencies [Line Items]
Litigation Settlement, Amount Awarded from Other Party	$ 1,430	$ 1,080
Estimated Litigation Liability, Noncurrent			$ 201	$ 201

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES (Guarantees) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Sadara Chemical Company [Member]
Guarantor Obligations [Line Items]
Equity Method Investment, Ownership Percentage	35%
Sadara Chemical Company [Member] | Total Project Financing [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	$ 334	$ 298
Performance Guarantee [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	1,643	1,385
Guarantor obligations, recorded liability	191	196
Performance Guarantee [Member] | Sadara Chemical Company [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	1,300
Performance Guarantee [Member] | Sadara Chemical Company [Member] | Sadara Chemical Company [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	500
Accounts Receivable Facilities Performance
Guarantor Obligations [Line Items]
Guarantor obligations, maximum future payments	$ 405	$ 150

LEASES COSTS AND OTHER INFORMAT

LEASES COSTS AND OTHER INFORMATION (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating Lease, Cost	$ 107	$ 98
Finance Lease, Right-of-Use Asset, Amortization	27	26
Finance Lease, Interest Expense	10	8
Finance Lease, Cost	37	34
Short-term Lease, Cost	74	66
Variable Lease, Cost	258	181
Sublease Income	(2)	(2)
Lease, Cost	474	377
Operating Lease, Payments	116	105
Finance Lease, Interest Payment on Liability	10	8
Finance Lease, Principal Payments	30	28
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	100	99
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	$ 70	$ 6

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ (7,814)	$ (7,065)	$ (7,681)
Other Comprehensive Income (Loss), Net of Tax	(133)	74
Derivative instruments	(22)	(64)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(259)	(222)	(253)	$ (253)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	15	30
Other Comprehensive Income (Loss), Tax	(18)	0
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(3)	30
Other Comprehensive Income (Loss), Net of Tax	(6)	31
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(4)	1
Reclassification from AOCI, Current Period, Tax	1	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(3)	1
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(2,013)	(1,833)	(1,891)	(1,934)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(116)	84
Other Comprehensive Income (Loss), Tax	(3)	2
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(119)	86
Other Comprehensive Income (Loss), Net of Tax	(122)	101
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	(3)	15
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(5,469)	(4,871)	(5,486)	(4,877)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(1)	2
Other Comprehensive Income (Loss), Net of Tax	17	6
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	22	3
Reclassification from AOCI, Current Period, Tax	(4)	1
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	18	4
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(73)	(139)	$ (51)	$ (75)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(33)	(183)
Other Comprehensive Income (Loss), Tax	3	33
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(30)	(150)
Derivative instruments	(22)	(64)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	10	109
Reclassification from AOCI, Current Period, Tax	(2)	(23)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	$ 8	$ 86

NONCONTROLLING INTERESTS Nonc_3

NONCONTROLLING INTERESTS Noncontrolling Interests (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Noncontrolling Interest [Line Items]
Balance at beginning of period	$ 501
Balance at end of period	492	$ 534
Noncontrolling Interest [Member]
Noncontrolling Interest [Line Items]
Balance at beginning of period	501	529
Net income attributable to noncontrolling interests	22	20
Distributions to noncontrolling interests	(14)	(13)
Cumulative translation adjustments	(16)	(3)
Other	(1)	1
Balance at end of period	$ 492	$ 534

PENSION PLANS AND OTHER POSTR_3

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pension Plan [Member]
Defined Benefit Plan Disclosures [Line Items]
Service cost	$ 14	$ 70
Interest cost	252	279
Expected return on plan assets	346	389
Amortization of prior service credit	(3)	(7)
Defined Benefit Plan, Amortization of (Gain) Loss	35	24
Net periodic benefit cost	(48)	(23)
Other Postretirement Benefits [Member]
Defined Benefit Plan Disclosures [Line Items]
Service cost	1	1
Interest cost	11	11
Defined Benefit Plan, Amortization of (Gain) Loss	(10)	(14)
Net periodic benefit cost	$ 2	$ (2)

STOCK-BASED COMPENSATION (Stock

STOCK-BASED COMPENSATION (Stock Incentive Plan) (Details) - $ / shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		1,300
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			$ 55.17
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 10.94
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate	10%
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	85%
Employee Stock Purchase Plan | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase shares subscribed by employees	2,500
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			2,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 55.18
Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			1,400
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			$ 58.42

Debt Investments (Details)

Debt Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales of available-for-sale securities	$ 721	$ 146
Gross realized gains	9	8
Available-for-sale Securities, Gross Realized Losses	(5)	(9)
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost	69
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value	65
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost	1,233
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value	1,132
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost	441
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value	405
Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost	505
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value	414
Debt Securities, Available-for-sale, Amortized Cost	2,248
Debt Securities, Available-for-sale	2,016
Equity Securities, Net Unrealized Gain (Loss)	0	$ (8)
Equity Securities, FV-NI, Current	14		$ 17
Equity Securities without Readily Determinable Fair Value, Amount	$ 169		$ 171

Notional Amounts (Details)

Notional Amounts (Details) $ in Millions	Mar. 31, 2024 USD ($) Boe	Dec. 31, 2023 USD ($) Boe
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	$ 3,000	$ 3,000
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	38	59
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	5,190	2,316
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Notional Amount	$ 12,645	$ 5,824
Commodity Contract Hydrocarbons | Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Nonmonetary Notional Amount | Boe	1,800,000	3,700,000
Commodity Contract Hydrocarbons | Not Designated as Hedging Instrument [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, Nonmonetary Notional Amount | Boe	1,800,000	1,400,000

Schedule of Fair Value of Deriv

Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	$ 161	$ 257
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(94)	(203)
Derivative Asset	67	54
Derivative Liability, Fair Value, Gross Liability	211	270
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(96)	(204)
Derivative Liability	115	66
Derivative Liability, Collateral, Right to Reclaim Cash, Offset	21	22
Derivative Asset, Collateral, Obligation to Return Cash, Offset	0	0
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	113	187
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(76)	(156)
Derivative Asset	37	31
Derivative Liability, Fair Value, Gross Liability	172	195
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(76)	(157)
Derivative Liability	96	38
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	48	70
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(18)	(47)
Derivative Asset	30	23
Derivative Liability, Fair Value, Gross Liability	39	75
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(20)	(47)
Derivative Liability	19	28
Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 76	$ 22
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent obligations	Other noncurrent obligations
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Noncurrent	$ 0	$ (3)
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Deferred charges and other assets	Deferred charges and other assets
Derivative Liability, Noncurrent	$ 0	$ 0
Derivative Asset, Current	0	0
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 0	$ 0
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Current	$ 0	$ 1
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 7	$ 3
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent obligations	Other noncurrent obligations
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Noncurrent	$ 0	$ (5)
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Deferred charges and other assets	Deferred charges and other assets
Derivative Liability, Noncurrent	$ 12	$ 0
Derivative Asset, Current	20	16
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 4	$ 22
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Current	$ 12	$ 17
Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 1	$ 12
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other noncurrent obligations	Other noncurrent obligations
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Noncurrent	$ (2)	$ (1)
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Deferred charges and other assets	Deferred charges and other assets
Derivative Liability, Noncurrent	$ 0	$ 1
Derivative Asset, Current	15	6
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	$ 15	$ 6
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Asset, Noncurrent	$ (3)	$ 0
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Deferred charges and other assets	Deferred charges and other assets
Derivative Asset, Current	$ 15	$ 5
Other Current Assets [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	47	73
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(47)	(73)
Other Current Assets [Member] | Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	1	4
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(1)	(3)
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	39	21
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(19)	(5)
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	21	33
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(9)	(16)
Other Current Assets [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	24	27
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(9)	(21)
Other Current Assets [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	23	33
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(8)	(28)
Deferred charges and other assets [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	0	59
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	0	(56)
Deferred charges and other assets [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	0	5
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	0	0
Deferred charges and other assets [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	3	2
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	(1)	(1)
Deferred charges and other assets [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	3	0
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset	0	0
Accrued and Other Current Liabilities [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	123	95
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(47)	(73)
Accrued and Other Current Liabilities [Member] | Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	1	3
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(1)	(3)
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	26	8
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(19)	(5)
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	13	38
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(9)	(16)
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	10	34
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(9)	(22)
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	25	34
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	(10)	(28)
Other Noncurrent Obligations [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	0	56
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	0	(56)
Other Noncurrent Obligations [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	12	0
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	0	0
Other Noncurrent Obligations [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	1	2
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset	$ (1)	$ (1)

Effect of Derivative Instrument

Effect of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	$ (22)	$ (64)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	(7)	(109)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(33)	(145)
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	61	28
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	0	0
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	1	5
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	(2)	(2)
Excluded Components [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(6)	0
Excluded Components [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net	(1)	0
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	6	3
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	3	0
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(38)	(1)
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net	0	0
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	31	35
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(13)	0
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	1	2
Foreign Exchange Contract [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	2	(9)
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	8	0
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	15	(143)
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Hedging Activity	(8)	(109)
Derivative
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	(33)	(145)
Derivative, Gain (Loss) on Derivative, Net	54	(81)
Total Return Swap | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0
Total Return Swap | Not Designated as Hedging Instrument [Member] | Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	$ 22	$ (7)

Expected Reclassification (Deta

Expected Reclassification (Details) $ in Millions	Mar. 31, 2024 USD ($)
Interest Rate Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	$ (4)
Commodity Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months	9
Foreign Exchange Contract [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	4
Excluded Components [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net	(5)
Excluded Components [Member] | Net Investment Hedging [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net	$ 6

FAIR VALUE MEASUREMENTS (Summar

FAIR VALUE MEASUREMENTS (Summary of Recurring Measured Fair Values) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	$ 1,240	$ 1,267
Debt Securities, Available-for-sale	2,016
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	161	257
Debt Securities, Available-for-sale, Amortized Cost	2,248
Equity Securities, FV-NI, Current	14	17
Long Term Debt, Accumulated Fair Value Adjustment	42	49
Derivative, Amount of Hedged Item	4,479	4,479
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity Securities, Amortized Cost Basis	4	5
Equity Securities, Accumulated Gross Unrealized Gain, Before Tax	10	12
Equity Securities, Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 1 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax	0	0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax	(3)	(2)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	2	2
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	20	24
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(2)	(3)
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term Debt	(16,288)	(15,024)
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax	1,311	1,089
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax	(581)	(747)
Available-for-sale Debt Securities, Amortized Cost Basis, Current	837	1,361
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Current, before Tax	0	0
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Current, before Tax	(66)	(61)
Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, at Carrying Value	789	485
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 2 [Member] | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, at Carrying Value	689	663
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax	0	0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax	(124)	(154)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	48	136
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax	0	0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax	(51)	(46)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	60	59
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax	0	0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax	(33)	(68)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	51	60
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	0	0
Fair Value, Inputs, Level 2 [Member] | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	914	766
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	2	3
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(109)	(107)
Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	1,114	1,148
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	16	17
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(102)	(99)
Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	200	200
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0	0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(37)	(89)
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	4,440	4,589
Total liabilities at fair value	(15,941)	(15,130)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity Securities, FV-NI, Current	14	17
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	2	2
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	(3)	(2)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	18	21
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale, Current	771	1,300
Long-term debt including debt due within one year 6	15,558	14,682
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, Fair Value	789	485
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents, Fair Value	689	663
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	48	136
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	(124)	(154)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	60	59
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	(51)	(46)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement	51	60
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement	(33)	(68)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | US Treasury and Government [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	807	662
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	1,028	1,066
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	85	86
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	17	18
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities and Real Estate [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments	75	75
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Sadara Chemical Company [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guarantees, Fair Value Disclosure	(172)	(178)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Method Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	0	7
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Securities, Available-for-sale	$ 163	$ 111

FAIR VALUE MEASUREMENTS (Summ_2

FAIR VALUE MEASUREMENTS (Summary of Nonrecurring Measured Fair Values) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net	$ 45			$ 541
Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges	37
2023 Restructuring Program
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net	8	$ 14	$ 8	541
2023 Restructuring Program | Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net				1
2023 Restructuring Program | Industrial Intermediates & Infrastructure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net	8	2	8	40
Asset write-downs and write-offs [Member] | 2023 Restructuring Program
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net	8	14	8	197
Asset write-downs and write-offs [Member] | 2023 Restructuring Program | Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net				1
Asset write-downs and write-offs [Member] | 2023 Restructuring Program | Industrial Intermediates & Infrastructure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring and asset related charges - net	8	$ 2	$ 8	$ 40
Fair Value, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member] | Manufacturing Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure	$ 60

SEGMENTS AND GEOGRAPHIC REGIO_3

SEGMENTS AND GEOGRAPHIC REGIONS Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 10,765	$ 11,851
Equity in earnings (losses) of nonconsolidated affiliates	17	(48)
Operating EBIT	674	708
Packaging & Specialty Plastics [Member]
Segment Reporting Information [Line Items]
Net sales	5,430	6,114
Equity in earnings (losses) of nonconsolidated affiliates	25	21
Operating EBIT	605	642
Industrial Intermediates & Infrastructure [Member]
Segment Reporting Information [Line Items]
Net sales	3,008	3,378
Equity in earnings (losses) of nonconsolidated affiliates	(15)	(73)
Operating EBIT	87	123
Performance Materials & Coatings [Member]
Segment Reporting Information [Line Items]
Net sales	2,152	2,276
Equity in earnings (losses) of nonconsolidated affiliates	6	3
Operating EBIT	41	35
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net sales	175	83
Equity in earnings (losses) of nonconsolidated affiliates	1	1
Operating EBIT	$ (59)	$ (92)

SEGMENTS AND GEOGRAPHIC REGIO_4

SEGMENTS AND GEOGRAPHIC REGIONS EBIT Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting [Abstract]
Net income (loss)	$ 538	$ (73)
Provision for income taxes	(89)	(47)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	449	(120)
Interest Income, Other	65	76
Interest Expense, Debt	199	185
Other Nonrecurring (Income) Expense	(91)	(719)
Operating EBIT	$ 674	$ 708

SEGMENTS AND GEOGRAPHIC REGIO_5

SEGMENTS AND GEOGRAPHIC REGIONS Significant Items (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Restructuring Charges	$ (91)	$ (551)
Gain (Loss) Related to Litigation Settlement		(177)
Charges related to separation, distribution and tax matters agreements		9
Other Nonrecurring (Income) Expense	(91)	(719)
Packaging & Specialty Plastics [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	(37)	(1)
Gain (Loss) Related to Litigation Settlement		0
Charges related to separation, distribution and tax matters agreements		0
Other Nonrecurring (Income) Expense	(37)	(1)
Industrial Intermediates & Infrastructure [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	(8)	(40)
Gain (Loss) Related to Litigation Settlement		(177)
Charges related to separation, distribution and tax matters agreements		0
Other Nonrecurring (Income) Expense	(8)	(217)
Performance Materials & Coatings [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	0	(67)
Gain (Loss) Related to Litigation Settlement		0
Charges related to separation, distribution and tax matters agreements		0
Other Nonrecurring (Income) Expense	0	(67)
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	(46)	(443)
Charges related to separation, distribution and tax matters agreements		9
Other Nonrecurring (Income) Expense	$ (46)	$ (434)